
<html lang="en"     class="pb-page"  data-request-id="5c96c3e0-929e-47fe-b17b-28eca580e299"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm400732v;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2013.56.issue-20"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain" /></meta><meta name="dc.Creator" content="Robert F.  Kester" /></meta><meta name="dc.Creator" content="Andrew F.  Donnell" /></meta><meta name="dc.Creator" content="Yan  Lou" /></meta><meta name="dc.Creator" content="Stacy W.  Remiszewski" /></meta><meta name="dc.Creator" content="Louis J.  Lombardo" /></meta><meta name="dc.Creator" content="Shaoqing  Chen" /></meta><meta name="dc.Creator" content="Nam T.  Le" /></meta><meta name="dc.Creator" content="Jennifer  Lo" /></meta><meta name="dc.Creator" content="John A.  Moliterni" /></meta><meta name="dc.Creator" content="Xiaochun  Han" /></meta><meta name="dc.Creator" content="J. Heather  Hogg" /></meta><meta name="dc.Creator" content="Weiling  Liang" /></meta><meta name="dc.Creator" content="Christophe  Michoud" /></meta><meta name="dc.Creator" content="Kenneth C.  Rupert" /></meta><meta name="dc.Creator" content="Steven  Mischke" /></meta><meta name="dc.Creator" content="Kang  Le" /></meta><meta name="dc.Creator" content="Martin  Weisel" /></meta><meta name="dc.Creator" content="Cheryl A.  Janson" /></meta><meta name="dc.Creator" content="Christine M.  Lukacs" /></meta><meta name="dc.Creator" content="Adrian J.  Fretland" /></meta><meta name="dc.Creator" content="Kyoungja  Hong" /></meta><meta name="dc.Creator" content="Ann  Polonskaia" /></meta><meta name="dc.Creator" content="Lin  Gao" /></meta><meta name="dc.Creator" content="Shirley  Li" /></meta><meta name="dc.Creator" content="Dave S.  Solis" /></meta><meta name="dc.Creator" content="Doug  Aguilar" /></meta><meta name="dc.Creator" content="Christine  Tardell" /></meta><meta name="dc.Creator" content="Mark  Dvorozniak" /></meta><meta name="dc.Creator" content="Shahid  Tannu" /></meta><meta name="dc.Creator" content="Edmund C.  Lee" /></meta><meta name="dc.Creator" content="Andy D.  Schutt" /></meta><meta name="dc.Creator" content="Barry  Goggin" /></meta><meta name="dc.Description" content="The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells. IAPs contain one to three BIR domains that are crucial for their inhibitory function. The ..." /></meta><meta name="Description" content="The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells. IAPs contain one to three BIR domains that are crucial for their inhibitory function. The ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 7, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400732v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400732v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400732v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400732v" /></link>
        
    
    

<title>Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400732v" /></meta><meta property="og:title" content="Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0019.jpeg" /></meta><meta property="og:description" content="The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells. IAPs contain one to three BIR domains that are crucial for their inhibitory function. The pro-survival properties of XIAP come from binding of the BIR domains to the pro-apoptotic caspases. The BIR3 domain of XIAP binds and inhibits caspase 9, while the BIR2 domain binds and inhibits the terminal caspases 3 and 7. While XIAP BIR3 inhibitors have previously been reported, they also inhibit cIAP1/2 and promote the release of TNFα, potentially limiting their therapeutic utility. This paper will focus on the optimization of selective XIAP BIR2 inhibitors leading to the discovery of highly potent benzodiazepinone 36 (IC50 = 45 nM), which has high levels of selectivity over XIAP BIR3 and cIAP1 BIR2/3 and shows efficacy in a xenograft pharmacodynamic model monitoring caspase activity while not promoting the release of TNFα in vitro." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400732v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400732v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400732v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400732v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400732v&amp;href=/doi/10.1021/jm400732v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7788-7803</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400731m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400196q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+F.++Kester">Robert F. Kester</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+F.++Donnell">Andrew F. Donnell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Lou">Yan Lou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacy+W.++Remiszewski">Stacy W. Remiszewski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis+J.++Lombardo">Louis J. Lombardo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaoqing++Chen">Shaoqing Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nam+T.++Le">Nam T. Le</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Lo">Jennifer Lo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Moliterni">John A. Moliterni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaochun++Han">Xiaochun Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Heather++Hogg">J. Heather Hogg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiling++Liang">Weiling Liang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Michoud">Christophe Michoud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+C.++Rupert">Kenneth C. Rupert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Mischke">Steven Mischke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kang++Le">Kang Le</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Weisel">Martin Weisel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheryl+A.++Janson">Cheryl A. Janson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+M.++Lukacs">Christine M. Lukacs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+J.++Fretland">Adrian J. Fretland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyoungja++Hong">Kyoungja Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Polonskaia">Ann Polonskaia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Gao">Lin Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shirley++Li">Shirley Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dave+S.++Solis">Dave S. Solis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Doug++Aguilar">Doug Aguilar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Tardell">Christine Tardell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Dvorozniak">Mark Dvorozniak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shahid++Tannu">Shahid Tannu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edmund+C.++Lee">Edmund C. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andy+D.++Schutt">Andy D. Schutt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry++Goggin">Barry Goggin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Discovery Chemistry, <sup>‡</sup>Discovery Technologies, <sup>§</sup>Non-clinical Safety, Early ADME, and <sup>∥</sup>Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#cdbfaba6a8beb9a8bf8db4aca5a2a2e3aea2a0"><span class="__cf_email__" data-cfemail="7d0f1b16180e09180f3d041c151212531e1210">[email protected]</span></a>. Phone: 973-498-8986.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400732v&amp;href=/doi/10.1021%2Fjm400732v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7788–7803</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 7, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 May 2013</li><li><span class="item_label"><b>Published</b> online</span>7 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400732v" title="DOI URL">https://doi.org/10.1021/jm400732v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7788%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BF.%2BKester%252C%2BAndrew%2BF.%2BDonnell%252C%2BYan%2BLou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D20%26contentID%3Djm400732v%26title%3DOptimization%2Bof%2BBenzodiazepinones%2Bas%2BSelective%2BInhibitors%2Bof%2Bthe%2BX-Linked%2BInhibitor%2Bof%2BApoptosis%2BProtein%2B%2528XIAP%2529%2BSecond%2BBaculovirus%2BIAP%2BRepeat%2B%2528BIR2%2529%2BDomain%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7803%26publicationDate%3DOctober%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400732v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2261</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400732v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;F. Kester&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;F. Donnell&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Lou&quot;},{&quot;first_name&quot;:&quot;Stacy&quot;,&quot;last_name&quot;:&quot;W. Remiszewski&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;J. Lombardo&quot;},{&quot;first_name&quot;:&quot;Shaoqing&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Nam&quot;,&quot;last_name&quot;:&quot;T. Le&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Lo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Moliterni&quot;},{&quot;first_name&quot;:&quot;Xiaochun&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Heather Hogg&quot;},{&quot;first_name&quot;:&quot;Weiling&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Michoud&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;C. Rupert&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Mischke&quot;},{&quot;first_name&quot;:&quot;Kang&quot;,&quot;last_name&quot;:&quot;Le&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Weisel&quot;},{&quot;first_name&quot;:&quot;Cheryl&quot;,&quot;last_name&quot;:&quot;A. Janson&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;M. Lukacs&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;J. Fretland&quot;},{&quot;first_name&quot;:&quot;Kyoungja&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Polonskaia&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Shirley&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Dave&quot;,&quot;last_name&quot;:&quot;S. Solis&quot;},{&quot;first_name&quot;:&quot;Doug&quot;,&quot;last_name&quot;:&quot;Aguilar&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Tardell&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Dvorozniak&quot;},{&quot;first_name&quot;:&quot;Shahid&quot;,&quot;last_name&quot;:&quot;Tannu&quot;},{&quot;first_name&quot;:&quot;Edmund&quot;,&quot;last_name&quot;:&quot;C. Lee&quot;},{&quot;first_name&quot;:&quot;Andy&quot;,&quot;last_name&quot;:&quot;D. Schutt&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;Goggin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;7788-7803&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400732v&quot;},&quot;abstract&quot;:&quot;The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells. IAPs contain one to three BIR domains that are crucial for their inhibitory function. The pro-survival properties of XIAP come from binding of the BIR domains to the pro-apoptotic caspases. The BIR3 domain of XIAP binds and inhibits caspase 9, while the BIR2 domain binds and inhibits the terminal caspases 3 and 7. While XIAP BIR3 inhibitors have previously been reported, they also inhibit cIAP1/2 and promote the release of TNFα, potentially limiting their therapeutic utility. This paper will focus on the optimization of selective XIAP BIR2 inhibitors leading to the discovery of highly potent benzodiazepinone 36 (IC50 = 45 nM), which has high levels of selectivity over XIAP BIR3 and cIAP1 BIR2/3 and shows efficacy in a xenograft pharmacodynamic model monitoring caspase activity while not promoting the release of TNFα in vitro.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400732v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400732v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400732v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400732v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400732v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400732v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400732v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400732v&amp;href=/doi/10.1021/jm400732v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400732v" /></input><a href="/doi/pdf/10.1021/jm400732v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400732v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400732v%26sid%3Dliteratum%253Aachs%26pmid%3D24093940%26genre%3Darticle%26aulast%3DKester%26date%3D2013%26atitle%3DOptimization%2Bof%2BBenzodiazepinones%2Bas%2BSelective%2BInhibitors%2Bof%2Bthe%2BX-Linked%2BInhibitor%2Bof%2BApoptosis%2BProtein%2B%2528XIAP%2529%2BSecond%2BBaculovirus%2BIAP%2BRepeat%2B%2528BIR2%2529%2BDomain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D20%26spage%3D7788%26epage%3D7803%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jmcmar.2013.56.issue-20/production/jmcmar.2013.56.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells. IAPs contain one to three BIR domains that are crucial for their inhibitory function. The pro-survival properties of XIAP come from binding of the BIR domains to the pro-apoptotic caspases. The BIR3 domain of XIAP binds and inhibits caspase 9, while the BIR2 domain binds and inhibits the terminal caspases 3 and 7. While XIAP BIR3 inhibitors have previously been reported, they also inhibit cIAP1/2 and promote the release of TNFα, potentially limiting their therapeutic utility. This paper will focus on the optimization of selective XIAP BIR2 inhibitors leading to the discovery of highly potent benzodiazepinone <b>36</b> (IC<sub>50</sub> = 45 nM), which has high levels of selectivity over XIAP BIR3 and cIAP1 BIR2/3 and shows efficacy in a xenograft pharmacodynamic model monitoring caspase activity while not promoting the release of TNFα in vitro.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A defining characteristic of tumor growth is the uncontrolled proliferation of cancer cells. In addition to abundant cell proliferation signals, faulty apoptotic mechanisms may contribute to the rapid expansion of the tumor cell population.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The final effectors of apoptosis are the cellular caspases, including the gatekeeper caspases 8 and 9 and the terminal caspases 3 and 7. The inhibitor of apoptosis proteins (IAPs), of which the X-linked inhibitor of apoptosis protein (XIAP) is a member, represent the final barrier to apoptosis by acting as regulators of the caspase activity, inhibiting their action and preventing the destruction of the cell.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In recent years, research has shown that there is a correlation between XIAP expression and patient outcomes in certain cancers. In adult and childhood de novo acute myeloid leukemia (AML), increased XIAP expression correlates to decreased survival times when compared to patients with low XIAP levels.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> More recently, it has been shown that XIAP expression levels correlate with tumor stage and degree of progression (metastatic disease) in melanoma.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In renal cell carcinoma, the XIAP expression levels correlated to the grade of RCC and predicted a worse prognosis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Small molecule inhibitors of XIAP that restore apoptosis to tumor cells might therefore be an effective treatment for cancers where XIAP is overexpressed.</div><div class="NLM_p">The members of the IAP family are characterized by the presence of one to three baculovirus IAP repeat (BIR) domains, each of which contains an approximately 80 amino acid zinc binding region.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> XIAP, the most well-characterized IAP member, is a 57 kDa protein that contains three BIR domains (BIR1–3) and a really interesting new gene (RING) domain which confers ubiquitin protein ligase (E3) activity. Other IAP family members, such as the closely related cellular inhibitor of apoptosis proteins (cIAP1 and cIAP2), also contain multiple BIR domains. XIAP is believed to be the only IAP that binds and directly inhibits the caspases via its BIR domains.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">There are two main pathways to initiate caspase-mediated cell death, the intrinsic and extrinsic pathways. The intrinsic pathway is activated in response to intracellular damage, such as that caused by chemotherapeutic agents, and leads to activation of caspase 9 via the apoptosome.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> On the other hand, the extrinsic pathway is activated by the binding of death ligands, such as FasL, TNF-related apoptosis-inducing ligand (TRAIL), and TNFα, to their respective death receptors, Fas, DR4 or DR5, and TNFR1, resulting in the activation of caspase 8.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Regardless of which signaling pathway is activated, both caspase 8 and 9 lead to activation of the terminal caspases 3 and 7.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> XIAP is able to inhibit both the intrinsic and extrinsic pathways through the binding of the BIR3 domain to caspase 9 and the BIR2 domain to the terminal caspases 3 and 7.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The inhibition of the caspases by XIAP can be antagonized by the endogenous mitochondrial protein Smac/DIABLO (second mitochondria-derived activator of caspases/direct IAP-binding protein with low p<i>I</i>) which is secreted from the mitochondria in response to pro-apoptotic stimuli.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The function of Smac/DIABLO is dependent on a four amino acid sequence (AVPI) at its <i>N</i>-terminus that binds to the BIR3 domain of XIAP and disrupts its interaction with the caspases.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This AVPI sequence served as the basis for much of the initial work in the XIAP antagonist field and resulted in a few small molecule IAP inhibitors<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> that have entered the clinic. Structure-based design efforts starting from the AVPI sequence by Shaomeng Wang’s group at the University of Michigan identified SM-406<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which was taken into phase I trials in partnership with Ascenta. In separate peptidomimetic approaches, Genentech identified GDC-0152<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (<b>2</b>) while Novartis identified LCL161<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<b>3</b>) as potent IAP inhibitors which have entered clinical trials.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The data for these Smac-mimetic compounds indicate these compounds are pan-IAP inhibitors with a preference for BIR3 binding. In addition to binding to XIAP, they also bind to cIAP1 and cIAP2. This results in the autoubiquitination and degradation of the cIAPs and activates the noncanonical NF-κB pathway, leading to the production of TNFα.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The pro-apoptotic effect of these compounds is potentially mediated through increased TNFα signaling, and it represents a potential liability due to the increase in TNFα levels. It was expected that selective targeting of the BIR2 domain of XIAP would disrupt the interaction with the terminal caspases 3 and 7 and promote apoptosis in a manner mechanistically distinct from the pan-IAP inhibitors with a preference for BIR3 binding, by not binding to cIAP1/2, and might result in different PD properties. A recent paper<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> from the Sanford–Burnham Institute described efforts leading to a submicrolar monovalent Smac-mimetic with modest selectivity (up to 7:1) for XIAP BIR2 versus XIAP BIR3 that could serve as a probe compound to investigate the effects of selective XIAP BIR2 inhibitors. In addition to these monomeric compounds, there has been work focused on dimeric Smac mimetics<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> that may bind BIR2 as well as BIR3, however, their overall activity may be different than a selective BIR2 monomeric compound.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IAP inhibitors. Values for <b>1</b> and <b>2</b> are from refs  <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a> and <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>, respectively. Values for <b>3</b> were generated in-house.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a <a href="https://doi.org/10.1021/jm400731m">previous paper</a>, we described the medicinal chemistry efforts leading to benzoxazepinone <b>4</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), which served as an in vivo proof of concept molecule<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and demonstrated that selective BIR2 XIAP inhibitors could potentiate the effects of a DR5 mAB in inducing apoptosis without causing the release of TNFα. However, this molecule was not adequate as a clinical lead due to CYP3A4-related in vitro safety issues. It exhibited strong CYP3A4 inhibition (IC<sub>50</sub> = 1.8 μM) and time-dependent inhibition (TDI) of CYP3A4 (<i>K</i><sub>I</sub> = 1.0 μM, <i>k</i><sub>inact</sub> = 0.043 min<sup>–1</sup>, <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> = 0.043 L/min/μmol) and displayed unacceptable CYP3A4 induction levels (CYP3A4 mRNA >40% of control at 10 μM <b>4</b>). In a parallel effort, we were investigating the benzodiazepinone series of compounds <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Due to similarities between these scaffolds, we anticipated the SAR would be transferrable to this series, and we planned to draw upon lessons from the benzoxazepinones to guide our exploration and optimization of the benzodiazepinone scaffold. It was also expected that there would be subtle differences between the two series due to the additional nitrogen in the core ring system which could serve as a handle for substitution. Our plan focused on the iterative exploration of the R1, R2, and R3 regions of <b>5</b> as defined in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. In particular, the R1 region provided a unique vector for optimization that was not available in the benzoxazepinones. From an analysis of the X-ray crystal structure of the benzoxazepinones, it was apparent that the nitrogen atom in the R1 region would be pointing into a solvent exposed area, and we believed it might be possible to use this nitrogen as a handle to introduce groups that could modulate the CYP3A4 inhibition and TDI liability. In conjunction with this, we planned to re-examine the R2 and R3 regions with a goal of minimizing CYP3A4 issues. In earlier work (data not shown), it was confirmed that the <i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine chain was optimal. This paper will detail the optimization of the benzodiazepinone series leading to the identification of compound <b>36</b>, a potential clinical candidate.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Benzoxazepinone proof-of-concept compound <b>4</b> and plan to address CYP3A4-related liabilities by exploration of benzodiazepinone scaffold <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The starting point for our investigation was based on an early analogue in the benzoxazepinone series with a naphthyl group in the R2 region. Our SAR exploration began with a small set of substituents in the R1 region to determine whether substitution is tolerated and to identify the optimal linker type, either acyl or alkyl. The unsubstituted benzodiazepinone <b>9</b> was prepared in four steps according to the synthesis outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. BOC-protected amino benzodiazepinone <b>6</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was deprotonated with 1.1 equiv of lithium hexamethyldisilazide, and the amide nitrogen was selectively alkylated with 1-(bromomethyl)naphthalene to afford the naphthyl-substituted analogue <b>7</b>. The alanine moiety was then installed by deprotection of the amine and coupling with BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine to yield <b>8</b>, which was deprotected to provide <b>9</b>. Acylated compounds <b>10a</b>–<b>b</b> were prepared via treatment of <b>8</b> with the corresponding acid chloride in the presence of a base, then removal of the BOC group. The final compounds were obtained and tested as the hydrochloride salts.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Unsubstituted and <i>N</i>-Acyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiHMDS, THF, −78 °C; 1-(bromomethyl)naphthalene, 78%; (b) HCl, 1,4-diox, rt, 99%; (c) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 80%; (d) for <b>10a</b>, AcCl; for <b>10b</b>, <i>i</i>-BuCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 37–82%; (e) HCl, 1,4-diox, rt, 70%–quant.</p></p></figure><div class="NLM_p">The <i>N</i>-alkyl analogues were synthesized in four steps from <b>7</b> as detailed in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compound <b>7</b> was either alkylated with methyl iodide in the presence of potassium carbonate to produce <b>11a</b> or treated with isovaleraldehyde under reductive amination conditions to produce <b>11b</b>. The deprotection, amide coupling, deprotection sequence provided compounds <b>12a</b> and <b>12b</b> as the hydrochloride salts.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Alkyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 30%; (b) isovaleraldehyde, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 85%; (c) HCl, 1,4-diox, rt, quant; (d) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 81%; (e) HCl, 1,4-diox, rt, quant.</p></p></figure><div class="NLM_p">The ability of the these compounds to inhibit XIAP BIR2 and BIR3 was determined using a TR-FRET assay measuring the displacement of a Smac derivative from either the BIR2 or BIR3 domain of XIAP. The results of this initial SAR exploration of the nitrogen substituents are displayed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The alkyl substituted compounds <b>12a</b> and <b>12b</b> were roughly of equal potency at BIR2 to the unsubstituted compound <b>9</b>. When the amide compounds <b>10a</b> and <b>10b</b> were tested, they showed approximately a 4-fold increase in potency over the corresponding alkyl compounds, <b>12a</b> and <b>12b</b>, while maintaining excellent selectivity over the BIR3 domain (>54.8 μM). This confirms that the R1 region is amenable to modification and supported our plan to explore it more exhaustively with the goal of modulating the CYP3A4 inhibition. Before continuing that effort, however, we explored the SAR in the other regions of the molecule to provide a starting point with greater BIR2 potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial SAR Exploration of <i>N</i>-Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">BIR2 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">BIR3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">4.39 ± 0.45 (2)</td><td class="colsep0 rowsep0" align="char" char=".">>54.8 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="char" char="±">0.928 ± 0.35 (3)</td><td class="colsep0 rowsep0" align="char" char=".">>54.8 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-BuCO</td><td class="colsep0 rowsep0" align="char" char="±">0.611 ± 0.11 (4)</td><td class="colsep0 rowsep0" align="char" char=".">>54.8 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">4.36 ± 0.40 (2)</td><td class="colsep0 rowsep0" align="char" char=".">>54.0 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">isopentyl</td><td class="colsep0 rowsep0" align="char" char="±">2.62 ± 0.28 (2)</td><td class="colsep0 rowsep0" align="char" char=".">>54.0 (2)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All compounds were HCl salts.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Values are reported as mean ± SD (number of determinations).</p></div></div></div><div class="NLM_p">Since the isovaleramide analogue <b>10b</b> provided the most potent BIR2 inhibitor, it was held constant while variation in the R2 region was explored in an effort to identify a naphthyl replacement with increased BIR2 potency. The selection of substituents was guided by the R2 region SAR from the benzoxazepinone series, where aromatic groups were preferred in this position. For synthetic efficiency, the route was modified to install the R2 region substituent at the end of the synthesis (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Starting from benzodiazepinone <b>6</b>, deprotection and amide coupling afforded intermediate <b>13</b>, which was selectively acylated on the aniline nitrogen by treatment with isovaleryl chloride to yield <b>14</b>. The R2 region substitution was introduced via alkylation with the appropriate alkyl bromide and cesium carbonate, followed by BOC deprotection with HCl to yield compounds <b>15a</b>–<b>c</b>. Compounds <b>18</b> and <b>21a</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, using chemistry analogous to that described for Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues to Explore the R2 Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCl, 1,4-diox, rt; (b) Boc<i>-N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, quant (2 steps); (c) <i>i</i>-BuCOCl, pyr, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 84%; (d) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (e) HCl, 1,4-diox, rt., 32%–quant (2 steps).</p></p></figure><div class="NLM_p">In the R2 region of the molecule, it was observed that while the benzyl and phenethyl derivatives (<b>15a</b> and <b>15b</b>, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) retain some BIR2 potency, they are not as potent as the naphthyl derivatives. Addition of an α-methyl group, compound <b>15c</b>, caused an approximately 4-fold loss of potency over the unsubstituted naphthyl compound <b>10b</b>, whereas the addition of a substituent at the 2-position of the naphthyl ring resulted in increased BIR2 potency. The 2-methylnaphthyl analogue <b>18</b> is about twice as potent as the unsubstituted analogue <b>10b</b>, and the 2-methoxynaphthyl ring in analogue <b>15d</b> provides another 2-fold increase over analogue <b>18</b>. It was the 6-bromo-2-methoxynaphthyl analogue <b>21a</b> that provided the most potent and first double-digit nanomolar compound, which was 10-fold more potent than the unsubstituted naphthyl <b>10b</b>. This SAR trend paralleled very closely that which was observed for the benzoxazepinone series, allowing the team to work on both series at the same time and transfer SAR lessons between the series and decrease the optimization time. Because the CYP3A4 inhibition was a known liability of the benzoxazepinone series, CYP3A4 inhibition data for all new derivatives was obtained and was used in conjunction with potency to guide the optimization of the benzodiazepinone series. While this effort in the R2 region brought the BIR2 potency into the desired range, the most potent analogues still had a CYP liability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Initial Exploration of the Naphthyl Region</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0012.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All compounds were HCl salts.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Values are reported as mean ± SD (number of determinations).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Not tested, the compound was not evaluated in this assay.</p></div></div><div></div></div><div class="NLM_p">In an attempt to address the CYP inhibition problem, we retained the most potent 6-bromo-2-methoxynaphthyl group and revisited the R1 region with the aim of identifying substituents that would maintain the BIR2 potency and selectivity while increasing the CYP3A4 IC<sub>50</sub>. The compounds were prepared as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, with methods analogous to those described for Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. We initially examined a selection of aromatic amides, ranging from the unsubstituted phenyl <b>21b</b> through a variety of substituted phenyl analogues <b>21c</b>–<b>j</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). These compounds were all very potent, with little deviation in activity against the BIR2 domain (IC<sub>50</sub> 6–35 nM). Substitution on the phenyl ring did not significantly affect potency and the substituent position also had little effect, as illustrated by the <i>para</i>-, <i>meta</i>-, and <i>ortho</i>-fluoro substituted compounds <b>21c</b>–<b>e</b> which all have similar potency. The electronic nature of the phenyl substituent also did not significantly impact potency. Phenyl rings with electron-withdrawing groups ranged in potency from 6 nM for the 4-(methylsulfone) substitution of <b>21g</b> to 35 nM for the 4-nitrophenyl analogue <b>21i</b>, while the electron-donating methyl group in <b>21f</b> is 6 nM. The substituted-phenyl compounds all retained high selectivity over BIR3 (>1000-fold), however, the CYP3A4 inhibition remained an issue for most compounds. Only the aniline analogue <b>21j</b>, which was formed by reduction of the nitro group of the precursor <b>21i</b> and which proceeded with concomitant hydrogenolysis of the bromine of the naphthyl moiety, had an improved CYP3A4 inhibition. This compound was not pursued further due to the potential liabilities of the aniline moiety. Heteroaromatic groups such as pyridine, pyrimidine, and furan, <b>21k</b>–<b>n</b>, have single-digit nanomolar potency at BIR2 but did not demonstrate any advantage regarding the CYP3A4 inhibition liability. The first evidence of being able to modulate CYP3A4 inhibition while retaining BIR2 potency came during the exploration of aliphatic amides. The acetate <b>21p</b> and the tetrahydropyranylcarboxylate <b>21o</b> were found to have good BIR2 potency with modest improvements in CYP3A4 inhibition. The greatest improvement in CYP3A4 inhibition came with the polar 2-(methylsulfonyl)acetate analogue <b>21q</b> that displayed 9 nM potency at BIR2 and a CYP3A4 IC<sub>50</sub> of 10 μM. This promising result validated our hypothesis that we could use this region of the molecule to modulate the CYP3A4 inhibition in a manner unavailable to the benzoxazepinone series. In addition to the amide linker, sulfonamides, ureas, and carbamates were also evaluated, however, these analogues were not as potent (data not shown).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N-</i>Acyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiHMDS, THF, −78 °C; for <b>16</b>, 1-(chloromethyl)-2-methylnaphthalene, KI, 69%; for <b>19</b>, 6-bromo-1-(chloromethyl)-2-methoxynaphthalene, NaI, 92%; (b) HCl, 1,4-diox, rt; (c) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 90%–quant (2 steps); (d) for <b>18</b>, <i>i</i>-BuCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 74%; for <b>21a</b>–<b>u</b> (except <b>21r</b>, which was made by a different route, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), R<sup>3</sup>COCl, pyr, CH<sub>2</sub>Cl<sub>2</sub>, 60–95% or R<sup>3</sup>CO<sub>2</sub>H, POCl<sub>3</sub>, pyr, 40%–quant; (e) for <b>21k</b>, H<sub>2</sub> (50 psi), 10% Pd/C, MeOH, rt; (f) HCl, 1,4-diox, rt, 69%–quant, or HCl, Et<sub>2</sub>O, MeOH, rt, 78%–quant.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exploration of R1 Region Amides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0014.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0015.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">All compounds were HCl salts.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Values that are the result of multiple determinations are reported as mean ± SD (number of determinations).</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Not tested, the compound was not evaluated in this assay.</p></div></div><div></div></div><div class="NLM_p">To better understand the binding mode and the specificity of these compounds, we obtained a crystal structure of <b>21j</b> bound to XIAP BIR2 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Consistent with published structures of BIR2 and BIR3, the alanine sits in the P1 pocket, pointing toward the face of Trp210, with the <i>N</i>-terminus surrounded by three acidic side chains. The core amide interacts with the protein in a β-strand like fashion. The aniline and naphthyl groups branch from the benzodiazepinone core and fill the P4 area. In particular, the carbonyl of the aniline amide accepts a hydrogen bond from the side chain of Asn209, while the face of the aniline sits against Lys208, making hydrophobic interactions with its alkyl chain. In BIR3, this residue is an aspartic acid and therefore cannot donate a hydrogen bond. The 2-methoxynaphthyl group is 4 Å away from and tilted about 65° relative to the plane of the aniline and is approaching the XIAP BIR2-specific narrow hydrophobic pocket created by space between the extended side chains of Lys206 and Lys208. The naphthyl group is positioned near Phe224 which is a tyrosine in BIR3 and, presumably, the hydroxyl group of the tyrosine would have an unfavorable interaction with the naphthyl, contributing to the BIR2 specificity of these compounds. Overall, the binding mode is similar to that observed with the benzoxazepinone series and supports our use of the SAR of that series to develop the foundation of the benzodiazepinone series and set the stage for subsequent optimization.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal structure of <b>21j</b> with XIAP BIR2 domain. (A) The protein is represented as an electrostatic surface. (B) Interactions of the ligand with the peptide-binding groove of the protein. H-bonding interactions between the protein and ligand are represented by black dotted lines labeled with the distance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because sulfone <b>21q</b> was very potent and selective for BIR2 and had an acceptable CYP3A4 inhibition value, it was progressed into a PK study in C57 mice. This compound exhibited moderately high clearance (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, 29 mL/min/kg), similar to the benzazepinone and benzoxazepinone series. In the benzazepinone series, metabolite identification studies showed that amide hydrolysis by an extrahepatic mechanism was one of the routes of clearance,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and we believed a similar mechanism could be operative in this series. In the benzoxazepinone series, an improvement in metabolic stability was observed with an increase in steric bulk adjacent to the amide bond. It was believed that the same strategy in the benzodiazepinone series might produce a more metabolically stable compound as well. To examine this hypothesis, we targeted the analogue of <b>21q</b> that has a <i>trans</i>-methyl group at the 4-position of the benzodiazepinone core. This configuration was chosen based on ease of access from intermediates derived from <span class="smallcaps smallerCapital">l</span>-threonine.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PK Properties of <b>21q</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">value for <b>21q</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">28.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">285</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Mouse cassette iv PK study, compound dosed iv at 0.5 mg/kg.</p></div></div></div><div class="NLM_p">The synthesis of the <i>trans</i>-methyl benzodiazepinone began with the nucleophilic substitution of the fluorine of 1-fluoro-2-nitrobenzene with the free amine of (2<i>S</i>,3<i>S</i>)-methyl 3-amino-2-(<i>tert</i>-butoxycarbonylamino)butanoate (<b>22</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> followed by saponification of the methyl ester, reduction of the nitro group by catalytic hydrogenation, and then cyclization under amide coupling conditions to provide the benzodiazepinone core <b>23</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Under conditions similar to those described above, the nitrogen was acylated using the acid chloride generated in situ from 2-(methanesulfonyl)acetic acid to provide <b>24</b> and the <i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine chain was installed, giving <b>25</b>. In the final set of steps, the R2 moiety was installed via alkylation of <b>25</b> with 6-bromo-1-(chloromethyl)-2-methoxynaphthalene in the presence of sodium iodide and cesium carbonate, and then acidic deprotection of the amine yielded compound <b>26a</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of <i>trans</i>-Methyl Benzodiazepinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: To prepare <b>26a</b>, the order of steps from <b>24</b> was: h, f, g, i. (a) 1-Fluoro-2-nitrobenzene for <b>23</b> or 3-fluoro-4-nitrobenzonitrile for <b>27</b>, NaHCO<sub>3</sub>, DMF, 85 °C, 78%; (b) LiOH, H<sub>2</sub>O–1,4-diox, rt; (c) H<sub>2</sub>, Pd/C, EtOH, rt; (d) EDCI, DMF, rt, 91% (3 steps) for <b>23</b>, 16% (3 steps) for <b>27</b>; (e) methanesulfonylacetic acid, POCl<sub>3</sub>, pyr, 0 °C, 89–94%; (f) for <b>25</b>, TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; for <b>29</b>, HCl, 1,4-diox, rt; (g) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, <i>i-</i>Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 74–91% (2 steps); (h) R<sup>2</sup> bromide or chloride, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, rt, 38–90%; (i) HCl, 1,4-diox, rt or Et<sub>2</sub>O–MeOH, rt or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">The modifications resulting in <b>26a</b> did, indeed, reduce the clearance in mouse from 28.9 mL/min/kg for <b>21q</b> to 7.5 mL/min/kg for <b>26a</b>, but the CYP3A4 IC<sub>50</sub> of 4.8 μM was now a concern (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). We profiled <b>26a</b> for CYP3A4 TDI and found this compound was a potent time-dependent inhibitor. The CYP3A4 TDI assay used was a modification of that described by Chen and co-workers<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> in which <i>k</i><sub>obs</sub> values for loss of enzyme activity in human liver microsomes over 30 min were determined in the presence of 10 and 50 μM concentrations of test compound. The TDI kinetic parameters <i>K</i><sub>I</sub> and <i>k</i><sub>inact</sub> were then estimated using Kitz–Wilson plots, and the inactivation potency is represented by the ratio <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub>. In the case of compound <b>26a</b>, the <i>k</i><sub>obs</sub> values indicated that it was a highly potent time-dependent inhibitor at both concentrations tested, but characteristics of the curves prevented the estimation of <i>K</i><sub>I</sub> and <i>k</i><sub>inact</sub>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. XIAP Activity, CYP3A4 Properties, and PK Properties of <b>26a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center"><b>26a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">XIAP activity</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR2 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">29.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">CYP3A4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 TDI</td><td class="colsep0 rowsep0" align="left">potent<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Mouse iv PK<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">2220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1310</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values are the result of a single determination.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last"><i>k</i><sub>obs</sub> values indicated potent TDI, but <i>K</i><sub>I</sub> and <i>k</i><sub>inact</sub> values could not be estimated due to characteristics of the curves.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Mouse cassette PK study, compound dosed iv at 1 mg/kg.</p></div></div></div><div class="NLM_p">Retaining the <i>trans</i>-methyl group on the diazepinone core and the sulfone moiety in R1, attention was directed at identifying modifications to the naphthyl region (R2) that would lead to improvements in the TDI and CYP3A4 inhibition issues. The synthesis of compounds <b>26b</b>–<b>g</b> was carried out according to the protocols described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, and they were profiled in the CYP3A4 inhibition and TDI assays and in cassette PK in C57 mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Moving the bromine to the 5-position in <b>26b</b> served to decrease the CYP3A4 IC<sub>50</sub> by almost 3-fold (1.7 μM) and had little effect on the other properties. The bromine group was removed in <b>26c</b>, which retained similar potency at BIR2, increased the CYP3A4 IC<sub>50</sub> by about 2-fold, and improved the TDI compared with <b>26a</b>. However the clearance in mouse increased to 14 mL/min/kg, twice that of <b>26a</b>. While the 2-methylnaphthyl compound <b>26d</b> had lower potency at BIR2, as expected, it possessed the highest CYP3A4 IC<sub>50</sub> value observed so far (32 μM). This compound also displayed a modest improvement in TDI, although the <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio was still unacceptable. These improvements came at the price of clearance, as compound <b>26d</b> had a clearance three times that of <b>26a</b>. Replacement of the naphthyl group with more polar heterocycles including benzoisoxazole, <b>26e</b>, <i>N</i>-methyl indazole, <b>26f</b>, and <i>N</i>-2-(cyanophenyl)-indazole, <b>26g</b>, resulted in compounds with BIR2 potencies ranging from 182 to 32 nM. Molecular modeling suggested the cyano group in the naphthyl replacement for <b>26g</b> would displace a water molecule in the crystal structure and make a hydrogen bond to the protein. While the replacement of the naphthyl group with these heterocycles led to improvements in the CYP 3A4 inhibition and favorable TDI for <b>26g</b>, clearance values in mouse were variable and, in the case of compound <b>26f</b>, was greater than mouse liver blood flow. While this approach did not provide a single molecule in which all the issues were addressed successfully, it did indicate that the 2-methoxynaphthyl and 2-methylnaphthyl groups provided a favorable balance of properties and could serve as acceptable R2 groups if the CYP inhibition and TDI issues could be further improved by modifications elsewhere.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Exploration of the R2 region of <i>trans</i>-Methyl Benzodiazepinone Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0016.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0017.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Compounds were HCl salts, except <b>26e</b> which was a TFA salt.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Values that are the result of multiple determinations are reported as mean ± SD (number of determinations).</p></div><div class="footnote" id="t6fn3"><sup>Table c</sup><p class="last">Mouse cassette PK study, compound dosed iv at 0.5 mg/kg except <b>26a</b>–<b>c</b>, which were dosed at 1 mg/kg.</p></div><div class="footnote" id="t6fn4"><sup>Table d</sup><p class="last"><i>k</i><sub>obs</sub> values indicated potent TDI, but <i>K</i><sub>I</sub> and <i>k</i><sub>inact</sub> values could not be estimated due to characteristics of the curves.</p></div><div class="footnote" id="t6fn5"><sup>Table e</sup><p class="last">Not determined, unable to estimate <i>K</i><sub>I</sub> and <i>k</i><sub>inact</sub> due to potent reversible inhibition.</p></div><div class="footnote" id="t6fn6"><sup>Table f</sup><p class="last">Not tested, the compound was not evaluated in this assay.</p></div></div><div></div></div><div class="NLM_p">At this point, the only area of the molecule that had not been modified was the phenyl ring of the benzodiazepinone system. We hypothesized that the phenyl ring of the core could potentially be oxidized to a reactive intermediate/metabolite that could account for the high TDI observed with these compounds. By making the ring more electron deficient, we might be able to mitigate this. Preliminary investigations indicated that cyano-substitution at the 7-position of the benzodiazepinone was tolerated, so we combined that with the two best R2 region groups, 2-methoxynaphthyl and 2-methylnapthyl, to give compounds <b>30a</b> and <b>30b</b> (the synthesis was carried out according to the protocols described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). These analogues exhibited a 2-fold improvement in potency at the BIR2 domain over the unsubstituted compounds <b>26c</b> and <b>26d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The in vitro safety data on these two compounds also showed a considerable improvement. The electron withdrawing groups added to the phenyl ring produced compounds with a low TDI signal and they also possessed a higher IC<sub>50</sub> for CYP3A4. These were the first compounds that satisfied our potency, selectivity, and in vitro safety criteria. However, the clearance for <b>30a</b> was approximately 3-fold greater than the unsubstituted compound <b>26c</b>, and for compound <b>30b</b> the clearance was approximately the same as the unsubstituted compound <b>26d</b>. In both cases, we believed the clearance could be improved.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Cyano-Substituted Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0018.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">CYP3A4 TDI</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">BIR2 <br /></br>IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">BIR3 <br /></br>IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CYP3A4 <br /></br>IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>I</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>inact</sub> (min<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub></th><th class="colsep0 rowsep0" align="center" char=".">CL <br /></br>(mL/min/kg)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30a</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">0.010</td><td class="colsep0 rowsep0" align="center">12.9</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">46.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">0.051 ± 0.003 (2)</td><td class="colsep0 rowsep0" align="center">37.8 ± 0.2 (2)</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">21.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">All compounds were HCl salts.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Values that are the result of multiple determinations are reported as: Mean ± SD (number of determinations).</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Mouse cassette PK study, compound dosed iv at 0.5 mg/kg.</p></div></div></div><div class="NLM_p">In the final attempt at identifying a compound with all the desired attributes, a decision was made to re-explore the R1 amide region. The initial group selected for chemistry optimization work was the acetyl group. The synthetic scheme to prepare these analogues was not as flexible as that for the earlier analogues. Attempts to acetylate <b>27</b> proceeded without selectivity for the aniline nitrogen and led to a mixture of mono- and bis-acylated products. This was addressed by installing the naphthyl group first (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Alkylation of the benzodiazepinone core <b>27</b> with the appropriately substituted chloromethylnaphthalene provided <b>31</b> and <b>34</b>. These were then acylated with acetyl chloride to provide <b>32</b> and <b>35</b>. The <i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine moiety was installed according to the standard procedure, providing the final compounds <b>33</b> and <b>36</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Optimized Benzodiazepinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(chloromethyl)-2-methoxynaphthalene or 1-(chloromethyl)-2-methoxynaphthalene, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, rt, 72–80%; (b) AcCl, pyr, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 59–65%; (c) HCl, 1,4-diox, rt; (d) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 69–70%; (e) HCl, 1,4-diox, rt, 80–87%.</p></p></figure><div class="NLM_p">Compounds <b>33</b> and <b>36</b> represented an optimal combination of substitutions that when tested in our assays possessed the key attributes of low TDI, low metabolic clearance in vivo, and a lowered potential for CYP3A4 inhibition (data summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). These two compounds were roughly equipotent at the BIR2 domain of XIAP and retained excellent selectivity against the BIR3 domain. They were also devoid of any in vitro safety flags. Replacing the 2-(methylsulfonyl)-acetyl group with the acetyl group caused a slight decrease in the CYP3A4 inhibition value, but it was still in an acceptable range and the TDI was low. Additionally, these compounds showed no significant inhibition of the CYP2D6 and CYP2C9 isoforms. Because benzoxazepinone <b>4</b> promoted CYP3A4 induction, we tested for this with <b>36</b> and did not observe any induction at concentrations of <b>36</b> up to 10 μM. In further profiling, no GSH adducts were observed in a GSH trapping assay for either <b>33</b> or <b>36</b>, and hERG inhibition was acceptable. Comparing these analogues to the 2-(methylsulfonyl)-acetyl compounds <b>30a</b> and <b>30b</b>, the greatest improvement was in their PK properties. The clearance values for <b>33</b> and <b>36</b> were the lowest observed in this series. Compound <b>33</b> exhibited modest oral bioavailability, while <b>36</b> had 28% bioavailability. We decided to progress compound <b>36</b> as our lead molecule based primarily on differences in protein binding. For <b>36</b>, the free fraction in mouse and human was comparable (0.51% vs 1.6%), whereas compound <b>33</b> showed a nearly 35-fold difference (0.08% vs 2.79%), which might result in issues in further development.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. XIAP, in Vitro Safety, and PK Properties of <b>33</b> and <b>36</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center"><b>33</b></th><th class="colsep0 rowsep0" align="center"><b>36</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">XIAP Activity</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP BIR2 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">0.022 ± 0.008 (2)</td><td class="colsep0 rowsep0" align="center">0.045 ± 0.006 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP BIR3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">23.2 ± 8.5 (2)</td><td class="colsep0 rowsep0" align="center">30.8 ± 3.18 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">in Vitro Safety</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2D6 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2C9 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 TDI <i>K</i><sub>I</sub> (μM)</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">16.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 TDI <i>k</i><sub>inact</sub> (min<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="center">0.018</td><td class="colsep0 rowsep0" align="center">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 TDI <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> (L/min/μmol)</td><td class="colsep0 rowsep0" align="center">0.0004</td><td class="colsep0 rowsep0" align="center">0.0005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP 3A4 induction</td><td class="colsep0 rowsep0" align="center">n.t.<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">no flag<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSH adduct formation</td><td class="colsep0 rowsep0" align="center">no flag</td><td class="colsep0 rowsep0" align="center">no flag</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>20</sub> (μM)</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">8.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">>20</td><td class="colsep0 rowsep0" align="center">35.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">mouse iv PK<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="center">3.0</td><td class="colsep0 rowsep0" align="center">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="center">0.52</td><td class="colsep0 rowsep0" align="center">0.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="center">3032</td><td class="colsep0 rowsep0" align="center">1378</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="center">1555</td><td class="colsep0 rowsep0" align="center">792</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">mouse po PK<a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="center">5980</td><td class="colsep0 rowsep0" align="center">7870</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="center">873</td><td class="colsep0 rowsep0" align="center">823</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Protein Binding</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse (% free)</td><td class="colsep0 rowsep0" align="center">0.08</td><td class="colsep0 rowsep0" align="center">0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human (% free)</td><td class="colsep0 rowsep0" align="center">2.8</td><td class="colsep0 rowsep0" align="center">1.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Values are reported as: Mean ± SD (number of determinations).</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Not tested, compound was not evaluated in this assay.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">No significant increase in CYP3A4 mRNA compared to control at up to 10 μM <b>36</b>.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Mouse cassette PK study, compound dosed iv at 0.5 mg/kg.</p></div><div class="footnote" id="t8fn5"><sup>e</sup><p class="last">Mouse single-dose PK study, compound dosed po at 10 mg/kg.</p></div></div></div><div class="NLM_p">Compound <b>36</b> was also tested for activity against the BIR2 and BIR3 domains of cIAP1 and was found to have high selectivity for XIAP, with 58-fold selectivity against cIAP1 BIR2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). Compound <b>36</b> was then evaluated in a caspase reactivation functional assay designed to support the proposed mechanism of action. Endogenous caspases obtained from HeLa S3 cell lysates were activated by treatment with cytochrome c and ATP and inhibited by the addition of full-length XIAP. The subsequent addition of <b>36</b> restored caspase activity in a dose-dependent manner with an EC<sub>50</sub> of 0.262 μM, measured by the cleavage of Ac-DEVD-AFC, a fluorogenic substrate specific for caspases 3 and 7. This confirms the relationship between XIAP BIR2 inhibition and apoptotic signaling in accordance with the mechanistic proposal.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Biological Characterization of <b>36</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">value<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">XIAP Activity</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR2 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.045 ± 0.006 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR3 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">30.8 ± 3.2 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">cIAP1 Activity</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR2 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">2.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR3 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>54.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">XIAP-Caspase Reactivation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.262 ± 0.024 (2)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Values that are the result of multiple determinations are reported as mean ± SD (number of determinations).</p></div></div></div><div class="NLM_p">To determine whether <b>36</b> maintained its activity in cellular systems, it was evaluated in a 5 day cell viability assay using SW620 cells. While compound <b>36</b> showed no single agent activity in the cellular assay, it had a significant effect on cell viability when dosed in combination with the DR5 antibody, conatumumab, which serves to activate the apoptotic signaling through the extrinsic pathway, and dose–response curves for the DR5 antibody alone and in the presence of increasing concentrations of <b>36</b> (0.37, 1.1, 3.3, and 10 μM) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) were generated. In the absence of test compound, no significant growth inhibition was observed. The combination of DR5 antibody and compound <b>36</b> exhibited a dose-dependent increase in cell growth inhibition, indicating that <b>36</b> is effective at sensitizing the SW620 cells to conatumumab. Similar growth inhibition behavior was observed with the BIR3-selective compound <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Compounds <b>3</b> and <b>36</b> were also tested in other cell lines and showed similar activity (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure 1">Supporting Information, Figure 1</a>). The selectivity of compound <b>36</b> for XIAP over cIAP was expected to decrease or eliminate the TNFα secretion observed with BIR3 antagonists, such as <b>3</b>. To confirm this, TNFα levels were measured following the treatment of MDA-MB-231<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> cells with either <b>36</b> or <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). No significant TNFα induction was observed with the BIR2-selective compound <b>36</b>, while <b>3</b> showed high TNFα levels at all concentrations where cellular activity was observed. The production of TNFα by BIR3-selective compounds is thought to arise from cIAP degradation, promoted by compound binding, which serves to activate the noncanonical NF-κB pathway.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Compound <b>21j</b>, a closely related analogue of <b>36</b>, did not promote degradation of cIAP1 in CHL-1 cells, where the BIR3-selective compound <b>3</b> did (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure 2">Supporting Information, Figure 2</a>).</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A,B) Cell-based activity of <b>36</b> and <b>3</b> in combination with DR5 antibody. Proliferation of SW620 cells was evaluated in a 5 day MTS assay upon treatment with DR5 antibody in the presence of varied concentrations of <b>36</b> and <b>3</b>. At 0.5 μg/mL DR5 mAb, <b>36</b> EC<sub>90</sub> = 5.23 ± 1.32 μM, <b>3</b> EC<sub>90</sub> = 6.66 ± 1.51 μM. Values are the mean of two determinations ± SD. (C) Presence of TNFα in supernate from MDA-231 cells 19 h after treatment with the BIR3-selective compound <b>3</b> and BIR2-selective compound <b>36</b>. Values are the mean of two determinations ± SD. (D) The in vivo activity of <b>3</b> and <b>36</b> in combination with the DR5 mAb conatumumab in a LOX melanoma xenograft study measuring caspase 3/7 activity. Mice with LOX xenografts were dosed with conatumumab (single dose 1 mg/kg ip) and test compound (single dose 200 mg/kg po for <b>36</b>; single dose 100 mg/kg po for <b>3</b>). Xenografts were removed after 8 h, homogenized, and analyzed for caspase 3/7 enzyme activity. Mean ± SEM is indicated for each group. Concentration of the test compound in plasma and tumor at 8 h was also determined (<b>36</b>, 5.0 μM plasma, 7.7 μM tumor; <b>3</b>, 3.3 μM plasma, 18.4 μM tumor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The compounds were then evaluated in a pharmacodynamic model designed to measure the level of caspase 3 and 7 activity. Compound <b>36</b>, XIAP BIR2 selective antagonist, and compound <b>3</b>, pan-IAP BIR3 antagonist, were examined in combination with conatumumab in nude mice implanted with LOX melanoma xenografts (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D). The compounds were administered as single doses (1 mg/kg ip for conatumumab, 200 mg/kg po for <b>36</b>, and 100 mg/kg po for <b>3</b>), and the xenografts were removed after 8 h and analyzed for caspase 3 and 7 activity. The LOX cell line is sensitive to the DR5 antibody, resulting in elevated caspase 3 and 7 levels upon treatment with conatumumab alone. While compound treatment alone resulted in little caspase 3 and 7 activity, in combination they significantly potentiated the activity of conatumumab and <b>36</b> displayed a level of activity comparable to that of <b>3</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">While pan-IAP inhibitors with selectivity for the BIR3 domain of XIAP, cIAP1, and cIAP2 have been reported in the literature, this, with our previous papers,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> is the first disclosure of a highly potent and selective XIAP BIR2 inhibitor. The discovery of benzodiazepinone <b>36</b> was driven by the iterative optimization of safety properties, CYP3A4 inhibition and TDI, starting from compound <b>9</b>. During the course of this optimization, poor clearance in vivo was an issue and was addressed by the placement of a <i>trans</i>-methyl group onto the core diazepinone ring, resulting in a compound suitable for in vivo studies. Compound <b>36</b> is highly potent and selective for XIAP BIR2 (∼700-fold selective over XIAP BIR3 and 58-fold selective over cIAP1 BIR2) and has acceptable safety and PK properties. This represents a substantial improvement in selectivity compared to the benzoxazepinone analogue reported in our previous paper, which was used to establish proof of concept for this mechanism. In combination with the DR5 antibody conatumumab, <b>36</b> demonstrated cellular efficacy and increased caspase 3 and 7 activity in a PD study in mouse xenografts. This activity does not proceed through pathways involving cIAP inhibition and TNFα release, differentiating <b>36</b> from known BIR3 inhibitors. Compound <b>36</b> will be profiled further in a tumor growth inhibition xenograft study and toxicology studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General</h4><div class="NLM_p last">Experimental procedures are given below for the preparation of <b>30a</b>–<b>b</b>, <b>33</b>, and <b>36</b> (including intermediates <b>27</b>–<b>35</b>). All commercially available reactants, reagents, and solvents were used as received. Reactions using air- or moisture-sensitive reagents were performed under an atmosphere of Ar or N<sub>2</sub>. Reactions were monitored by LC-MS or TLC. Flash chromatography was performed with Isco CombiFlash Companion or AnaLogix IntelliFlash chromatography systems using prepacked silica gel columns (40–60 μm particle size RediSep or 20–40 μm spherical silica gel RediSep Gold columns purchased from Teledyne Isco, or comparable products from other vendors). Preparative HPLC was performed using a Waters HPLC system consisting of a 2767 sample manager, 2525 binary gradient module, and 2996 photodiode array detector with a SunFire Prep C18 OBD column (5 μm, 30 mm × 100 mm) eluted with a 10–100% MeCN–H<sub>2</sub>O linear gradient with 0.1% v/v TFA at a flow rate of 30 mL/min, or using similar methods on a comparable system. NMR spectra were measured on Bruker 300 or 400 MHz spectrometers. Chemical shifts are reported in ppm downfield from TMS using residual nondeuterated solvent as an internal standard (CHCl<sub>3</sub>, 7.26 ppm; DMSO, 2.50 ppm). Data are reported in the form: chemical shift (multiplicity, coupling constants, integration). Multiplicities are recorded by the following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. HRMS data were recorded on a ThermoFisher OrbiTrap FTMS system using flow injection with electrospray ionization in positive mode. Analytical HPLC and LC-MS analyses were performed using either Waters or Agilent LC-MS systems. The Waters system was comprised of a ZQ mass spectrometer using multimode (ES/APCI) ionization with alternating ± switching and an ES Industries Chromegabond WR C18 column (3 μm, 120 Å, 30 mm × 3.2 mm) eluted with a 10–90% MeCN–H<sub>2</sub>O linear gradient with 0.1% v/v TFA. The Agilent system was comprised of a 6140 mass spectrometer using multimode (ES/APCI) ionization with alternating ± switching and an Agilent Zorbax SB C-18 column (3.5 μm, 30 mm × 2.1 mm) eluted with a 10–90% MeCN–H<sub>2</sub>O linear gradient with 0.1% v/v TFA. All tested compounds were evaluated on one of these analytical HPLC systems and determined to be ≥95% pure.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-7-Cyano-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylcarbamate (<b>27</b>)</h4><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Step 1</h5><div class="NLM_p last">A suspension of <b>22</b> (6.49 g, 27.9 mmol), 3-fluoro-4-nitrobenzonitrile (6.96 g, 41.9 mmol), and sodium bicarbonate (7.04 g, 83.8 mmol) in DMF was stirred at 65 °C for 3 h. The reaction was cooled and concentrated. The residue was diluted with H<sub>2</sub>O (100 mL) and extracted with EtOAc (2 × 150 mL). The combined organic layers were washed with H<sub>2</sub>O (50 mL) and satd aq NaCl (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (330 g silica gel; 5–50% EtOAc–hexanes) to provide (2<i>S</i>,3<i>S</i>)-methyl 2-(<i>tert</i>-butoxycarbonylamino)-3-(5-cyano-2-nitrophenylamino)butanoate (8.2 g, 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (d, <i>J =</i> 8.8 Hz, 1H), 8.06 (d, <i>J =</i> 9.0 Hz, 1H), 7.66 (s, 1H), 7.59 (d, <i>J =</i> 8.5 Hz, 1H), 7.08 (d, <i>J =</i> 8.8 Hz, 1H), 4.46 (dd, <i>J =</i> 8.4, 4.6 Hz, 1H), 4.42–4.32 (m, 1H), 3.67 (s, 3H), 1.35 (s, 9H), 1.20 (d, <i>J =</i> 7.3 Hz, 3H). MS <i>m</i>/<i>z</i> 401 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Step 2</h5><div class="NLM_p last">To a rt solution of (2<i>S</i>,3<i>S</i>)-methyl 2-(<i>tert</i>-butoxycarbonylamino)-3-(5-cyano-2-nitrophenylamino)butanoate (8.2 g, 21.7 mmol) in 1,4-dioxane–H<sub>2</sub>O (1:1, 80 mL) was added 1.3 M aq LiOH (41.7 mL, 54.2 mmol). The reaction was stirred for 2 h. The reaction was acidified with 0.5 M aq HCl (to pH 5) and extracted with EtOAc (2 × 100 mL). The combined organic layers were washed with H<sub>2</sub>O (50 mL) and satd aq NaCl (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to provide (2<i>S</i>,3<i>S</i>)-2-(<i>tert</i>-butoxycarbonylamino)-3-(5-cyano-2-nitrophenylamino)butanoic acid (7.9 g, 100%) that was used without further purification. MS <i>m</i>/<i>z</i> 365 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Step 3</h5><div class="NLM_p last">To a rt solution of (2<i>S</i>,3<i>S</i>)-2-(<i>tert</i>-butoxycarbonylamino)-3-(5-cyano-2-nitrophenylamino)butanoic acid (7.9 g, 21.7 mmol) in MeOH (75 mL) was added 10% palladium on carbon (800 mg). The atmosphere was exchanged for H<sub>2</sub>, and the reaction was stirred for 4 h. The mixture was filtered through Celite and concentrated to provide (2<i>S</i>,3<i>S</i>)-3-(2-amino-5-cyanophenylamino)-2-(<i>tert</i>-butoxycarbonylamino)butanoic acid (7.25 g, 100%) that was used without further purification. MS <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Step 4</h5><div class="NLM_p last">To a rt solution of (2<i>S</i>,3<i>S</i>)-3-(2-amino-5-cyanophenylamino)-2-(<i>tert</i>-butoxycarbonylamino)butanoic acid (7.25 g, 21.7 mmol) in DMF (85 mL) was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (5.4 g, 28.2 mmol). The reaction was stirred overnight. The reaction was concentrated, diluted with H<sub>2</sub>O (150 mL), and extracted with EtOAc (2 × 150 mL). The combined organic layers were washed with H<sub>2</sub>O (50 mL), satd aq NaHCO<sub>3</sub> (50 mL), H<sub>2</sub>O (50 mL), and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel; 20%–70% EtOAc–hexanes) to provide <b>27</b> (1.12 g, 16%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.07 (s, 1H), 7.36–7.28 (m, 2H), 7.15 (d, <i>J =</i> 8.5 Hz, 1H), 7.10–7.03 (m, 1H), 5.41 (s, 1H), 3.77–3.60 (m, 2H), 1.36 (s, 9H), 1.12 (d, <i>J =</i> 5.8 Hz, 3H). MS <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-8-Cyano-2-methyl-1-(2-(methylsulfonyl)acetyl)-4-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylcarbamate (<b>28</b>)</h4><div class="NLM_p last">To a 0 °C solution of <b>27</b> (106 mg, 335 μmol) in pyridine (3.35 mL) was added 2-(methylsulfonyl)acetic acid (50.9 mg, 369 μmol) followed by phosphorus oxychloride (61.3 μL, 670 μmol) dropwise. The reaction was stirred at 0 °C for 30 min, then quenched by the addition of H<sub>2</sub>O and extracted with EtOAc. The combined organic layers were washed with 1 N aq citric acid, H<sub>2</sub>O, satd aq NaHCO<sub>3</sub>, and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (12 g silica gel; 0–100% EtOAc–hexanes) to provide <b>28</b> (137 mg, 94%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (br s, 1H), 7.98 (d, <i>J =</i> 8.3 Hz, 1H), 7.91 (s, 1H), 7.48 (d, <i>J =</i> 9.1 Hz, 1H), 7.35 (d, <i>J =</i> 8.3 Hz, 1H), 5.07–4.91 (m, 1H), 4.14 (d, <i>J =</i> 15.5 Hz, 1H), 3.76 (dd, <i>J =</i> 11.7, 9.1 Hz, 1H), 3.66 (d, <i>J =</i> 15.5 Hz, 1H), 3.10 (s, 3H), 1.35 (s, 9H), 1.12 (d, <i>J =</i> 6.0 Hz, 3H). MS <i>m</i>/<i>z</i> 459 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (<i>S</i>)-1-((2<i>S</i>,3<i>S</i>)-8-Cyano-2-methyl-1-(2-(methylsulfonyl)acetyl)-4-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (<b>29</b>)</h4><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Step 1</h5><div class="NLM_p last">A rt solution of <b>28</b> (137 mg, 314 μmol) in 4 M HCl in 1,4-dioxane (1.57 mL) was stirred for 2 h. The reaction was concentrated and used without further purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) d = 11.00 (s, 1H), 8.54 (br s, 3H), 8.09–7.94 (m, 2H), 7.38 (d, <i>J =</i> 7.9 Hz, 1H), 5.26–5.11 (m, 1H), 4.20 (d, <i>J =</i> 15.1 Hz, 1H), 3.96 (d, <i>J =</i> 10.6 Hz, 1H), 3.71 (d, <i>J =</i> 15.5 Hz, 1H), 3.09 (s, 3H), 1.28 (d, <i>J =</i> 6.4 Hz, 3H).</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Step 2</h5><div class="NLM_p last">This material was taken up in DMF (1.05 mL), and Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine (70.2 mg, 345 μmol), <i>N</i>,<i>N</i>-diisopropylethylamine (217 μL, 1.26 mmol), and HBTU (131 mg, 345 μmol) were added at 0 °C. The reaction was stirred at rt for 30 min, then diluted with EtOAc, washed with H<sub>2</sub>O, satd aq NaHCO<sub>3</sub>, and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (12 g RediSep Gold silica gel; 20–100% EtOAc–hexanes) to provide <b>29</b> (121.8 mg, 74%, 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (s, 1H), 8.41 (d, <i>J =</i> 8.3 Hz, 1H), 7.99 (d, <i>J =</i> 8.3 Hz, 1H), 7.93 (s, 1H), 7.35 (d, <i>J =</i> 8.3 Hz, 1H), 5.19–5.05 (m, 1H), 4.59–4.31 (m, 1H), 4.22–3.98 (m, 2H), 3.68 (d, <i>J =</i> 15.5 Hz, 1H), 3.10 (s, 3H), 2.75–2.65 (m, 3H), 1.37 (s, 9H), 1.30–1.19 (m, 3H), 1.11 (d, <i>J =</i> 6.0 Hz, 3H). MS <i>m</i>/<i>z</i> 544 [M + Na]<sup>+</sup>.</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-7-Cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>30a</b>)</h4><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Step 1</h5><div class="NLM_p last">To a rt solution of <b>29</b> (108 mg, 207 μmol) in DMF (518 μL) was added 1-(chloromethyl)-2-methoxynaphthalene (47.1 mg, 228 μmol), cesium carbonate (81.0 mg, 248 μmol), and sodium iodide (37.2 mg, 248 μmol). The reaction was stirred at rt for 1.5 h, then diluted with EtOAc, washed with H<sub>2</sub>O and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (12 g RediSep Gold silica gel; 40–100% EtOAc–hexanes) then preparative HPLC to provide <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-7-cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (55 mg, 38%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.63 (d, <i>J</i> = 8.7 Hz, 1H), 8.13–7.81 (m, 5H), 7.57 (s, 1H), 7.47–7.30 (m, 3H), 5.91 (d, <i>J</i> = 15.1 Hz, 1H), 5.37 (d, <i>J</i> = 14.7 Hz, 1H), 4.95 (dq, <i>J</i> = 11.9, 5.9 Hz, 1H), 4.65–4.38 (m, 1H), 4.08 (dd, <i>J</i> = 11.7, 8.3 Hz, 1H), 3.86 (s, 3H), 2.87 (s, 3H), 2.73 (s, 3H), 2.10 (d, <i>J</i> = 15.1 Hz, 1H), 1.44–1.25 (m, 13H), 0.98 (d, <i>J</i> = 6.0 Hz, 3H). MS <i>m</i>/<i>z</i> 714 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Step 2</h5><div class="NLM_p last">A rt solution of <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-7-cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (55 mg, 79.5 μmol) in 4 M HCl in 1,4-dioxane (398 μL) was stirred for 1 h. The reaction was diluted with Et<sub>2</sub>O and the solids were collected by vacuum filtration, taken up in MeCN–H<sub>2</sub>O, and lyophilized to provide <b>30a</b> (41.6 mg, 83%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.30 (d, <i>J =</i> 8.7 Hz, 1H), 8.89 (br s, 2H), 8.16–8.03 (m, 2H), 8.01–7.93 (m, 1H), 7.92–7.85 (m, 2H), 7.61 (d, <i>J =</i> 1.1 Hz, 1H), 7.46–7.30 (m, 3H), 5.92 (d, <i>J =</i> 14.7 Hz, 1H), 5.40 (d, <i>J =</i> 14.7 Hz, 1H), 4.86 (dq, <i>J =</i> 11.9, 6.0 Hz, 1H), 4.13 (dd, <i>J =</i> 11.7, 8.7 Hz, 1H), 3.93–3.76 (m, 4H), 2.87 (s, 3H), 2.49–2.47 (m, 3H), 2.13 (d, <i>J =</i> 15.1 Hz, 1H), 1.46 (d, <i>J =</i> 6.8 Hz, 3H), 1.36 (d, <i>J =</i> 15.1 Hz, 1H), 1.03 (d, <i>J =</i> 6.4 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>34</sub>O<sub>6</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 592.22243, found 592.22174.</div></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-7-Cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>30b</b>)</h4><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Step 1</h5><div class="NLM_p last">To a rt solution of <b>29</b> (246 mg, 472 μmol) in DMF (1.18 mL) was added 1-(chloromethyl)-2-methylnaphthalene (98.9 mg, 519 μmol), cesium carbonate (184 mg, 566 μmol), and sodium iodide (84.8 mg, 566 μmol). The reaction was stirred at rt for 1 h. The reaction was diluted with EtOAc (60 mL), washed with H<sub>2</sub>O (60 mL) and satd aq NaCl (60 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (40 g RediSep Gold silica gel; 20–100% EtOAc–hexanes) to provide <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (261 mg, 82% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (d, <i>J</i> = 8.3 Hz, 1H), 8.13 (d, <i>J</i> = 8.3 Hz, 1H), 8.01–7.92 (m, 2H), 7.85 (d, <i>J</i> = 7.9 Hz, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 1H), 7.65 (s, 1H), 7.53–7.37 (m, 2H), 7.28 (d, <i>J</i> = 8.7 Hz, 1H), 5.97 (d, <i>J</i> = 15.5 Hz, 1H), 5.50 (d, <i>J</i> = 15.1 Hz, 1H), 5.04–4.91 (m, 1H), 4.62–4.41 (m, 1H), 4.05 (dd, <i>J</i> = 11.7, 8.7 Hz, 1H), 2.99 (s, 3H), 2.73 (s, 3H), 2.63 (d, <i>J</i> = 15.1 Hz, 1H), 2.46 (s, 3H), 1.92 (d, <i>J</i> = 15.1 Hz, 1H), 1.42–1.25 (m, 12H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H). MS <i>m</i>/<i>z</i> 698 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Step 2</h5><div class="NLM_p last">A rt solution of <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-5-(2-(methylsulfonyl)acetyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (260 mg, 385 μmol) in 4 M HCl in dioxane (1.92 mL) was stirred for 1 h. The reaction was added, dropwise, to a stirred vial of Et<sub>2</sub>O (20 mL), and the solids were collected by vacuum filtration (washed with Et<sub>2</sub>O (3 × 4 mL)). This material was taken up in MeCN–H<sub>2</sub>O and lyophilized to provide <b>30b</b> (210 mg, 89% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.30 (d, <i>J</i> = 8.3 Hz, 1H), 8.92 (br s, 2H), 8.12 (d, <i>J</i> = 8.3 Hz, 1H), 8.04–7.93 (m, 2H), 7.86 (d, <i>J</i> = 7.6 Hz, 1H), 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.69 (d, <i>J</i> = 1.1 Hz, 1H), 7.54–7.37 (m, 2H), 7.29 (d, <i>J</i> = 8.3 Hz, 1H), 5.97 (d, <i>J</i> = 15.5 Hz, 1H), 5.52 (d, <i>J</i> = 15.5 Hz, 1H), 4.89 (dq, <i>J</i> = 11.9, 6.1 Hz, 1H), 4.10 (dd, <i>J</i> = 11.7, 8.7 Hz, 1H), 3.86 (q, <i>J</i> = 6.8 Hz, 1H), 3.00 (s, 3H), 2.68 (d, <i>J</i> = 15.5 Hz, 1H), 2.48 (s, 3H), 2.46 (s, 3H), 1.96 (d, <i>J</i> = 15.1 Hz, 1H), 1.47 (d, <i>J</i> = 6.8 Hz, 3H), 1.04 (d, <i>J</i> = 6.0 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>34</sub>O<sub>5</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 576.22752, found 576.22644.</div></div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-7-Cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylcarbamate (<b>31</b>)</h4><div class="NLM_p last">To a rt solution of <b>27</b> (406 mg, 1.28 mmol) in DMF (3.21 mL) was added 1-(chloromethyl)-2-methoxynaphthalene (318 mg, 1.54 mmol) and cesium carbonate (1.25 g, 3.85 mmol). The reaction was stirred at rt for 16 h, then diluted with EtOAc, washed with H<sub>2</sub>O and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (40 g silica gel; 0–100% EtOAc–hexanes) to provide <b>31</b> (448 mg, 72%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.07 (d, <i>J</i> = 8.7 Hz, 1H), 7.81–7.70 (m, 2H), 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.42–7.34 (m, 1H), 7.34–7.24 (m, 4H), 7.07 (d, <i>J</i> = 1.5 Hz, 1H), 5.82 (d, <i>J</i> = 14.7 Hz, 1H), 5.29 (d, <i>J</i> = 14.7 Hz, 1H), 4.82 (s, 1H), 3.83 (s, 3H), 3.78–3.59 (m, 2H), 1.37 (s, 9H), 0.98 (d, <i>J</i> = 5.7 Hz, 3H). MS <i>m</i>/<i>z</i> 509 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-5-Acetyl-7-cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylcarbamate (<b>32</b>)</h4><div class="NLM_p last">To a 0 °C solution of <b>32</b> (448 mg, 921 μmol) in CH<sub>2</sub>Cl<sub>2</sub> (9.21 mL) was added pyridine (375 μL, 4.6 mmol), followed by acetyl chloride (78.8 μL, 1.1 mmol) dropwise. The reaction was stirred at 0 °C for 1 h, then allowed to warm to rt and stirred for an additional 20 h, then quenched by the addition of H<sub>2</sub>O and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with satd aq NaHCO<sub>3</sub> and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (40 g silica gel; 0–100% EtOAc–hexanes) to provide <b>32</b> (316 mg, 65%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05–7.86 (m, 3H), 7.83–7.73 (m, 2H), 7.71–7.67 (m, 1H), 7.58 (d, <i>J</i> = 9.1 Hz, 1H), 7.38–7.24 (m, 3H), 5.99 (d, <i>J</i> = 14.7 Hz, 1H), 5.34 (d, <i>J</i> = 14.7 Hz, 1H), 4.82 (dq, <i>J</i> = 12.0, 6.1 Hz, 1H), 3.92–3.82 (m, 3H), 3.69 (dd, <i>J</i> = 11.9, 8.9 Hz, 1H), 1.37 (s, 9H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H), 0.09 (s, 3H). MS <i>m</i>/<i>z</i> 551 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-5-Acetyl-7-cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>33</b>)</h4><div id="sec4_1_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Step 1</h5><div class="NLM_p last">A rt solution of <b>32</b> (316 mg, 598 μmol) in 4 M HCl in 1,4-dioxane (2.99 mL) was stirred for 2 h. The reaction was diluted with Et<sub>2</sub>O and the solids were collected by vacuum filtration to provide (3<i>S</i>,4<i>S</i>)-5-acetyl-3-amino-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepine-7-carbonitrile hydrochloride (216 mg, 78%) as a white solid that was used without further purification. MS <i>m</i>/<i>z</i> 429 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Step 2</h5><div class="NLM_p last">To a 0 °C solution of (3<i>S</i>,4<i>S</i>)-5-acetyl-3-amino-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepine-7-carbonitrile hydrochloride (216 mg, 465 μmol) in DMF (1.55 mL) was added Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine (104 mg, 511 μmol), <i>N</i>,<i>N</i>-diisopropylethylamine (322 μL, 1.86 mmol), and HBTU (194 mg, 511 μmol). The reaction was stirred at rt for 30 min, then diluted with H<sub>2</sub>O, and the solids were collected by vacuum filtration, taken up in EtOAc, washed with H<sub>2</sub>O, satd aq NaHCO<sub>3</sub>, and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (12 g silica gel; 20–100% EtOAc–hexanes) to provide <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-5-acetyl-7-cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (255 mg, 89%) as a white solid. MS <i>m</i>/<i>z</i> 636 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_9_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Step 3</h5><div class="NLM_p last">A rt solution of <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-5-acetyl-7-cyano-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (255 mg, 416 μmol) in 4 M HCl in 1,4-dioxane (2.08 mL) was stirred for 45 min. The reaction was diluted with Et<sub>2</sub>O and the solids were collected by vacuum filtration, taken up in MeCN–H<sub>2</sub>O, and lyophilized to provide <b>33</b> (181.8 mg, 80%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.27 (d, <i>J =</i> 8.3 Hz, 1H), 8.91 (br s, 2H), 8.09–7.97 (m, 2H), 7.91 (d, <i>J =</i> 7.9 Hz, 1H), 7.84–7.72 (m, 3H), 7.40–7.25 (m, 3H), 5.99 (d, <i>J =</i> 15.1 Hz, 1H), 5.36 (d, <i>J =</i> 14.7 Hz, 1H), 4.85 (dq, <i>J =</i> 11.8, 6.0 Hz, 1H), 4.08 (dd, <i>J =</i> 11.5, 8.5 Hz, 1H), 3.94–3.78 (m, 4H), 2.48 (s, 3H), 1.47 (d, <i>J =</i> 7.2 Hz, 3H), 0.95 (d, <i>J =</i> 6.0 Hz, 3H), 0.10 (s, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>32</sub>O<sub>4</sub>N<sub>5</sub> [M + H]<sup>+</sup> 514.24488, found 514.24353.</div></div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-7-Cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylcarbamate (<b>34</b>)</h4><div class="NLM_p last">To a rt solution of <b>27</b> (308 mg, 974 μmol) in DMF (2.43 mL) was added 1-(chloromethyl)-2-methylnaphthalene (223 mg, 1.17 mmol) and cesium carbonate (952 mg, 2.92 mmol). The reaction was stirred at rt for 2 h, then diluted with EtOAc, washed with H<sub>2</sub>O and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (40 g silica gel; 0–100% EtOAc–hexanes) to provide <b>34</b> (364 mg, 80%) as an off-white oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (d, <i>J =</i> 7.8 Hz, 1H), 7.79–7.73 (m, 1H), 7.65 (d, <i>J =</i> 8.6 Hz, 1H), 7.45–7.35 (m, 2H), 7.29–7.19 (m, 3H), 7.17–7.11 (m, 2H), 5.77–5.69 (m, 1H), 5.46 (d, <i>J =</i> 15.2 Hz, 1H), 4.99 (s, 1H), 3.79–3.64 (m, 2H), 2.44 (s, 3H), 1.38 (s, 9H), 1.00 (d, <i>J =</i> 5.3 Hz, 3H). MS <i>m</i>/<i>z</i> 493 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-5-Acetyl-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylcarbamate (<b>35</b>)</h4><div class="NLM_p last">To a 0 °C solution of <b>35</b> (364 mg, 774 μmol) in CH<sub>2</sub>Cl<sub>2</sub> (7.74 mL) was added pyridine (306 mg, 315 μL, 3.87 mmol), followed by acetyl chloride (71.8 μL, 1.01 mmol) dropwise. The reaction was stirred at 0 °C for 1 h, then allowed to warm to rt and stirred for an additional 15 h, then quenched by the addition of H<sub>2</sub>O and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with satd aq NaHCO<sub>3</sub> and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (40 g silica gel; 0–100% EtOAc–hexanes) (2×) to provide <b>35</b> (235 mg, 59%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09–8.03 (m, 2H), 7.91 (dd, <i>J =</i> 8.3, 1.8 Hz, 1H), 7.76 (d, <i>J =</i> 7.8 Hz, 1H), 7.73 (d, <i>J =</i> 1.8 Hz, 1H), 7.64 (d, <i>J =</i> 8.6 Hz, 1H), 7.59 (d, <i>J =</i> 8.8 Hz, 1H), 7.41 (t, <i>J =</i> 7.5 Hz, 1H), 7.35–7.28 (m, 1H), 7.20 (d, <i>J =</i> 8.3 Hz, 1H), 6.13 (d, <i>J =</i> 15.4 Hz, 1H), 5.38 (d, <i>J =</i> 15.2 Hz, 1H), 4.82 (dq, <i>J =</i> 12.1, 6.1 Hz, 1H), 3.66 (dd, <i>J =</i> 11.9, 8.8 Hz, 1H), 2.52 (s, 3H), 1.37 (s, 9H), 0.93 (d, <i>J =</i> 6.3 Hz, 3H), 0.31 (s, 3H). MS <i>m</i>/<i>z</i> 535 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>S</i>)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-5-Acetyl-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>36</b>)</h4><div id="sec4_1_12_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Step 1</h5><div class="NLM_p last">A rt solution of <b>35</b> (235 mg, 458 μmol) in 4 M HCl in 1,4-dioxane (2.29 mL) was stirred for 2 h. The reaction was diluted with Et<sub>2</sub>O and the solids were collected by vacuum filtration to provide (3<i>S</i>,4<i>S</i>)-5-acetyl-3-amino-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepine-7-carbonitrile hydrochloride (162 mg, 79%) as a white solid that was used without further purification. MS <i>m</i>/<i>z</i> 413 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Step 2</h5><div class="NLM_p last">To a 0 °C solution of (3<i>S</i>,4<i>S</i>)-5-acetyl-3-amino-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepine-7-carbonitrile hydrochloride (162 mg, 361 μmol) in DMF (1.2 mL) was added Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine (80.7 mg, 397 μmol), <i>N</i>,<i>N</i>-diisopropylethylamine (250 μL, 1.44 mmol), and HBTU (151 mg, 397 μmol). The reaction was stirred at rt for 30 min, then diluted with H<sub>2</sub>O, and the solids were collected by vacuum filtration, taken up in EtOAc, washed with H<sub>2</sub>O, satd aq NaHCO<sub>3</sub>, and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (12 g silica gel; 20–100% EtOAc–hexanes) to provide <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-5-acetyl-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (189 mg, 88%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (d, <i>J =</i> 8.7 Hz, 1H), 8.11–8.02 (m, 2H), 7.94 (dd, <i>J =</i> 8.5, 1.7 Hz, 1H), 7.80–7.71 (m, 2H), 7.64 (d, <i>J =</i> 8.3 Hz, 1H), 7.42 (t, <i>J =</i> 7.4 Hz, 1H), 7.35–7.27 (m, 1H), 7.20 (d, <i>J =</i> 8.7 Hz, 1H), 6.15 (d, <i>J =</i> 15.5 Hz, 1H), 5.35 (d, <i>J =</i> 15.5 Hz, 1H), 5.00–4.85 (m, 1H), 4.69–4.36 (m, 1H), 4.00 (dd, <i>J =</i> 11.7, 8.3 Hz, 1H), 2.73 (s, 3H), 2.53 (s, 3H), 1.43–1.22 (m, 12H), 0.91 (d, <i>J =</i> 6.0 Hz, 3H), 0.30 (s, 3H). MS <i>m</i>/<i>z</i> 620 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_12_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Step 3</h5><div class="NLM_p last">A rt solution of <i>tert</i>-butyl (<i>S</i>)-1-((3<i>S</i>,4<i>S</i>)-5-acetyl-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (187 mg, 313 μmol) in 4 M HCl in 1,4-dioxane (1.56 mL) was stirred for 45 min. The reaction was diluted with Et<sub>2</sub>O and the solids were collected by vacuum filtration, taken up in MeCN–H<sub>2</sub>O, and lyophilized to provide <b>36</b> (145.5 mg, 87%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.28 (d, <i>J =</i> 8.3 Hz, 1H), 8.93 (br s, 2H), 8.15–8.02 (m, 2H), 7.97 (dd, <i>J =</i> 8.3, 1.5 Hz, 1H), 7.83–7.74 (m, 2H), 7.66 (d, <i>J =</i> 8.3 Hz, 1H), 7.43 (t, <i>J =</i> 7.4 Hz, 1H), 7.37–7.28 (m, 1H), 7.21 (d, <i>J =</i> 8.3 Hz, 1H), 6.16 (d, <i>J =</i> 15.5 Hz, 1H), 5.37 (d, <i>J =</i> 15.5 Hz, 1H), 4.85 (dq, <i>J =</i> 12.0, 6.1 Hz, 1H), 4.05 (dd, <i>J =</i> 11.7, 8.3 Hz, 1H), 3.85 (q, <i>J =</i> 6.8 Hz, 1H), 2.53 (s, 3H), 2.48 (s, 3H), 1.48 (d, <i>J =</i> 7.2 Hz, 3H), 0.96 (d, <i>J =</i> 6.0 Hz, 3H), 0.30 (s, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>32</sub>O<sub>3</sub>N<sub>5</sub> [M + H]<sup>+</sup> 498.24997, found 498.24890.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Biology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> CYP3A4 TDI Assay</h4><div class="NLM_p last">A mixture containing either 10 or 50 μM test compound, 1 mg/mL human liver microsomes, 100 mM sodium phosphate (pH 7.4), 1 mM EDTA, and 3 mM magnesium chloride was incubated at 37 °C for 10 min. The preincubation was initiated by addition of NADPH (final concentration 1 mM). Preincubations were allowed to proceed for 0.5, 2.5, 5, 10, 15, 20, 25, and 30 min. At each time point, an aliquot was taken and added to a reaction mixture containing 10 μM midazolam. This reaction was allowed to proceed for 5 min at 37 °C then terminated by the addition of an equal volume of acetonitrile. Midazolam hydroxylation was determined using LC-MS/MS. Midazolam metabolite peak areas were normalized, with 100% activity set to the reaction rate of the DMSO control at 0.5 min of preincubation time. The natural log of normalized reaction rate was plotted against preincubation time, and rate constants (<i>k</i><sub>obs</sub>) for loss of enzyme activity were calculated. Only points in the linear range were considered for the determination of <i>k</i><sub>obs</sub>. Estimation of TDI parameters, <i>K</i><sub>I</sub> and <i>k</i><sub>inact</sub>, were performed using Kitz–Wilson double reciprocal plots.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> XIAP BIR2 and BIR3 TR-FRET Assay</h4><div class="NLM_p last">Ten nanomolar of 6× histidine-tagged BIR2 (amino acids 124–240) or BIR3 (amino acids 241–356) domain of the XIAP protein was mixed with 20 nM of the peptide AVPIAQKSEK (ε-biotin)–OH 1:2 TFA in the presence of 50 mM Tris-Cl (pH 7.5), 100 mM NaCl, 1 mM dithiothreitol (DTT), and 0.1 mg/mL bovine serum albumin (BSA). Following a 45 min incubation at 37 °C, europium–streptavidin and allophycocyanin conjugated anti-histidine antibody were added to a final concentration of 1.5 nM and 15 nM, respectively. Time-resolved fluorescence resonance energy transfer (TR-FRET) signals were measured after 1 h at rt. Compound potency was assessed at 10 serially diluted concentrations. Percentage of inhibition at each concentration was determined to generate an IC<sub>50</sub> value for each compound. Typically, <i>Z</i>′ = ∼0.9.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A measure of the overall variability of the assay is provided by the positive control: BIR2 IC<sub>50</sub> = 1.25 ± 0.91 μM (<i>n</i> = 160), BIR3 IC<sub>50</sub> = 0.039 ± 0.025 μM (<i>n</i> = 168).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> cIAP1 BIR2 AND BIR3 TR-FRET Assay</h4><div class="NLM_p last">Thirty nanomolar of 6× histidine–thrombin–TEV tagged BIR2 (amino acids 174–256) or BIR3 (amino acids 260–352) domain of the cIAP protein was mixed with 50 nM of the peptide AVPIAQKSEK (ε-biotin)–OH 1:2 TFA in the presence of 50 mM Tris-Cl (pH 7.5), 100 mM NaCl, 1 mM dithiothreitol (DTT), and 0.1 mg/mL bovine serum albumin (BSA). Following a 45 min incubation at 37 °C, europium–streptavidin and allophycocyanin conjugated anti-histidine antibody were added to a final concentration of 1.5 and 15 nM, respectively. Time-resolved fluorescence resonance energy transfer (TR-FRET) signals were measured after 1 h at rt. Compound potency was assessed at 10 serially diluted concentrations. Percentage of inhibition at each concentration was determined to generate an IC<sub>50</sub> value for each compound.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> XIAP-Caspase Reactivation Assay</h4><div class="NLM_p last">The caspase reactivation assay was performed in 20 mM HEPES buffer (pH 7.0), containing 1.5 mM MgCl<sub>2</sub>, 5 mM KCl, 1 mM ethylene diamine tetraacetic acid (EDTA), 1 mM ethylene glycol tetraacetic acid (EGTA), 1 mM DTT, and 0.1 mg/mL BSA. S-100 cell extract served as the source of cellular caspases. Then 2 μM cytochrome C and 19.2 μM dATP were added to activate the caspases. The cleavage of a fluorogenic substrate specific for caspase-3 and -7, Ac-DEVD-AFC at 10 μM, was monitored at 530 nm after 4 h of incubation at rt. The addition of 0.75 nM glutathione S-transferase (GST)-tagged full length XIAP inhibited the caspase activation by ∼85%. The effect of serially diluted compounds to restore caspase activation was determined to generate an EC<sub>50</sub> value for each compound.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Cell-Based Assay</h4><div class="NLM_p last">SW-620 cells (1500 cells/well) were seeded into a 96 well plate one day prior to treatment. Next day, cells were treated with indicated compounds and/or antibody and further incubated at 37 °C with 5% CO<sub>2</sub> for 5 d. Cell Titer 96 Aqueous One solution (25 μL/well, Promega cat. no.  G3580) was added, and the plates were further incubated for 2–3 h. Plates OD at 490 nm was determined using Envision 2101 plate reader (PerkinElmer), and EC<sub>50</sub> values were determined for compounds or antibody.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> TNFα ELISA Assay</h4><div class="NLM_p last">MDA-231 cells (400000 cells/well) were seeded into 24 well plates and incubated for 24 h. Next day, media was aspirated from wells and replaced with either compound or media alone (400 μL/well) and further incubated at 37 °C with 5% CO<sub>2</sub> for an additional 19 h. Total media volume was then collected and centrifuged (1000<i>g</i>) at 4 °C to pellet debris. TNF of media was quantitated by ELISA (TNF Human ELISA kit, R&D Systems cat. no. DTA00B) and results plotted following subtraction of background values (media, no cells).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> LOX Xenograft PD Study</h4><div class="NLM_p last">The study was carried out with LOX xenografts in female nude mice (d 15). A single dose of compound was administered as follows: conatumumab 1 mg/kg ip, <b>3</b> 100 mg/kg po, <b>36</b>, and 200 mg/kg po. Xenografts were removed 8 h postdose, frozen (−80 °C), transferred to 15 mL conical tubes on dry ice, and treated with 1× lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% TX-100, 5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 10 mM sodium fluoride, 1 mM Na<sub>3</sub>VO<sub>4</sub>, and 1 mM benzamidine. EMD proteinase inhibitor cocktail V) (1 mL per ∼0.1 g (if tumor is big >0.4, add 1 mL/0.2 g). Tumors were homogenized at full speed, diluted with the same volume of lysis buffer, and kept on ice for 20 min. A portion of the homogenate (2 mL) was transferred to a microcentrifuge tube and thawed at full speed for 20 min at 4 °C. The supernatant was optionally centrifuged again. Protein was quantitated and samples were prepared for caspase assay and Western blot analysis (50 μg of total protein was used for caspase assay/60 μg of total protein was used for Western blot). Tumor lysate (10 μL, 5 μg/μL) was added into white solid 96 well plate. Caspase-3/7 assay buffer (final concentration: 10 mM Tris, 5 mM DTT, 1 mM EDTA, 50 μM DEVD-AMC, 20 mM NaCl, 1% NP-40) (90 μL) was added into each well. The plate was incubated for 2 h at rt with shaking and read at 385/460 nM.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/jm400732v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Full procedures for compounds <b>7</b> through <b>26a</b>–<b>f</b>, crystallographic method, data collection, and refinement statistics. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400732v/suppl_file/jm400732v_si_001.pdf">jm400732v_si_001.pdf (879.96 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for <b>21j</b> bound to XIAP BIR2 shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU">4KJU</a>.</p><div class="testing" data-doi="10.1021/jm400732v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert F. Kester</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5426323f3127203126142d353c3b3b7a373b39"><span class="__cf_email__" data-cfemail="f28094999781869780b28b939a9d9ddc919d9f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew F. Donnell</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Lou</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacy W. Remiszewski</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis J. Lombardo</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaoqing Chen</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nam T. Le</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Lo</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Moliterni</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaochun Han</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Heather Hogg</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiling Liang</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Michoud</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth C. Rupert</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Mischke</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kang Le</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Weisel</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheryl A. Janson</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine M. Lukacs</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian J. Fretland</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyoungja Hong</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Polonskaia</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Gao</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shirley Li</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dave S. Solis</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Doug Aguilar</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Tardell</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Dvorozniak</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shahid Tannu</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edmund C. Lee</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andy D. Schutt</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry Goggin</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery
Chemistry, ‡Discovery Technologies, §Non-clinical Safety,
Early ADME, and ∥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d627e4665-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Pamela Carroll and Dr. David Heimbrook for their helpful discussions and support, Charles Belunis for protein purification, Santina Russo and Joachim Diez of Expose for data collection at SLS, and Kuresh Youdim and Volkmar Starke for providing support for the TDI assay.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">IAPs</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis proteins</p></td></tr><tr><td class="NLM_term">XIAP</td><td class="NLM_def"><p class="first last">X-linked inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">cIAP</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">BIR</td><td class="NLM_def"><p class="first last">baculovirus IAP repeat domains</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor alpha</p></td></tr><tr><td class="NLM_term">Smac</td><td class="NLM_def"><p class="first last">second mitochondria-derived activator of caspases</p></td></tr><tr><td class="NLM_term">DIABLO</td><td class="NLM_def"><p class="first last">direct IAP-binding protein with low p<i>I</i></p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time dependent inhibition</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">RING</td><td class="NLM_def"><p class="first last">really interesting new gene</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">TNF-related apoptosis-inducing ligand</p></td></tr><tr><td class="NLM_term">HBPyU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-bis(tetramethylene)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lheF6S3wZ0uMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, J. M.</span><span> </span><span class="NLM_article-title">Caspase activation—stepping on the gas or releasing the brakes? Lessons from humans and flies</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2774-2784&author=G.+S.+Salvesenauthor=J.+M.+Abrams&title=Caspase+activation%E2%80%94stepping+on+the+gas+or+releasing+the+brakes%3F+Lessons+from+humans+and+flies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DAbrams%26aufirst%3DJ.%2BM.%26atitle%3DCaspase%2520activation%25E2%2580%2594stepping%2520on%2520the%2520gas%2520or%2520releasing%2520the%2520brakes%253F%2520Lessons%2520from%2520humans%2520and%2520flies%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2774%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creutzig, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karawajew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, W.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuchter, C.</span><span> </span><span class="NLM_article-title">High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3737</span><span class="NLM_x">–</span> <span class="NLM_lpage">3744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1158%2F1078-0432.CCR-03-0642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3737-3744&author=I.+Tammauthor=S.+Richterauthor=D.+Oltersdorfauthor=U.+Creutzigauthor=J.+Harbottauthor=F.+Scholzauthor=L.+Karawajewauthor=W.-D.+Ludwigauthor=C.+Wuchter&title=High+Expression+Levels+of+X-Linked+Inhibitor+of+Apoptosis+Protein+and+Survivin+Correlate+with+Poor+Overall+Survival+in+Childhood+de+Novo+Acute+Myeloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia</span></div><div class="casAuthors">Tamm, Ingo; Richter, Stephan; Oltersdorf, Doreen; Creutzig, Ursula; Harbott, Jochen; Scholz, Frank; Karawajew, Leonid; Ludwig, Wolf-Dieter; Wuchter, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3737-3744</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Apoptosis-related proteins are important mols. for predicting chemotherapy response and prognosis in adult acute myeloid leukemia (AML).  However, data on the expression and prognostic impact of these mols. in childhood AML are rare.  Using flow cytometry and Western blot anal., the authors, therefore, investigated 45 leukemic cell samples from children with de novo AML enrolled and treated within the German AML-BFM93 study for the expression of apoptosis-regulating proteins [CD95, Bcl-2, Bax, Bcl-xL, procaspase-3, X-linked inhibitor of apoptosis protein (XIAP), cellular inhibitor of apoptosis protein-1 (cIAP-1), survivin].  XIAP but no other apoptosis regulators showed maturation-dependent expression differences as detd. by French-American-British (FAB) morphol. with the highest expression levels obsd. within the immature M0/1 subtypes.  XIAP and Bcl-xL expression was lower in patients with favorable rather than intermediate/poor cytogenetics.  After a mean follow-up of 34 mo, a shorter overall survival was assocd. with high expression levels of XIAP [30 vs. 41 mo; ] and survivin [27 vs. 41 mo; ].  Thus, the authors conclude that apoptosis-related mols. are assocd. with maturation stage, cytogenetic risk groups, and therapy outcome in childhood de novo AML.  The obsd. assocn. of XIAP with immature FAB types, intermediate/poor cytogenetics, and poor overall survival should be confirmed within prospective pediatric AML trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1ZJd4xSI97Vg90H21EOLACvtfcHk0lheF6S3wZ0uMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKntr0%253D&md5=334d7a3d4ba005c1ff4fc804f88d59f0</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0642%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DRichter%26aufirst%3DS.%26aulast%3DOltersdorf%26aufirst%3DD.%26aulast%3DCreutzig%26aufirst%3DU.%26aulast%3DHarbott%26aufirst%3DJ.%26aulast%3DScholz%26aufirst%3DF.%26aulast%3DKarawajew%26aufirst%3DL.%26aulast%3DLudwig%26aufirst%3DW.-D.%26aulast%3DWuchter%26aufirst%3DC.%26atitle%3DHigh%2520Expression%2520Levels%2520of%2520X-Linked%2520Inhibitor%2520of%2520Apoptosis%2520Protein%2520and%2520Survivin%2520Correlate%2520with%2520Poor%2520Overall%2520Survival%2520in%2520Childhood%2520de%2520Novo%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D3737%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tamm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karawajew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haferlach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuchter, C.</span><span> </span><span class="NLM_article-title">XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis</span> <span class="citation_source-journal">Hematol. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2Fsj.thj.6200549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=15570290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVagtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=489-495&author=I.+Tammauthor=S.+Richterauthor=F.+Scholzauthor=K.+Schmelzauthor=D.+Oltersdorfauthor=L.+Karawajewauthor=D.+Schochauthor=T.+Haferlachauthor=W.+D.+Ludwigauthor=C.+Wuchter&title=XIAP+expression+correlates+with+monocytic+differentiation+in+adult+de+novo+AML%3A+impact+on+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis</span></div><div class="casAuthors">Tamm, Ingo; Richter, Stephan; Scholz, Frank; Schmelz, Karin; Oltersdorf, Doreen; Karawajew, Leonid; Schoch, Claudia; Haferlach, Torsten; Ludwig, Wolf-Dieter; Wuchter, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Hematology Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">489-495</span>CODEN:
                <span class="NLM_cas:coden">HJEOBZ</span>;
        ISSN:<span class="NLM_cas:issn">1466-4860</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antiapoptotic proteins like the inhibitor of apoptosis proteins (IAPs) are mol. markers potentially useful for the characterization of acute myeloid leukemia (AML).  The authors screened 92 adults with de novo AML for the protein expression of various IAPs, Bcl-2 family members and the proform of Caspase-3 using quant. immunoblot and flow cytometry.  XIAP expression correlated with myelomonocytic French-American-British (FAB) subtypes M4/M5 and expression of monocytic markers (CD14, CD36, CD4, HLA-DR) in AML blasts.  In addn., XIAP was overexpressed in normal monocytes but undetectable in granulocytes.  In AML, XIAP expression was significantly lower in patients with favorable than intermediate or poor cytogenetics.  In total, 62 of the examd. patients were treated according to the German AML Cooperative Group (AMLCG) 92 protocol.  These patients were analyzed for prognostic significance of apoptosis-related proteins.  Patients expressing low levels of XIAP enjoyed better overall survival than patients expressing high amts. of XIAP (mean, 9 vs. 19 mo).  Other IAPs, most importantly Survivin, were of no prognostic value.  The authors conclude that XIAP but not other IAP family members is assocd. with monocytic differentiation in normal and malignant myelopoiesis, and may be of prognostic significance for overall survival in adult de novo AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppTLew01DAx7Vg90H21EOLACvtfcHk0lheF6S3wZ0uMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVagtrzP&md5=5b0941f3eb48d464c9df45cb930817b8</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fsj.thj.6200549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.thj.6200549%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DRichter%26aufirst%3DS.%26aulast%3DScholz%26aufirst%3DF.%26aulast%3DSchmelz%26aufirst%3DK.%26aulast%3DOltersdorf%26aufirst%3DD.%26aulast%3DKarawajew%26aufirst%3DL.%26aulast%3DSchoch%26aufirst%3DD.%26aulast%3DHaferlach%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DW.%2BD.%26aulast%3DWuchter%26aufirst%3DC.%26atitle%3DXIAP%2520expression%2520correlates%2520with%2520monocytic%2520differentiation%2520in%2520adult%2520de%2520novo%2520AML%253A%2520impact%2520on%2520prognosis%26jtitle%3DHematol.%2520J.%26date%3D2004%26volume%3D5%26spage%3D489%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kluger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvero, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sznol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimm, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, G.</span><span> </span><span class="NLM_article-title">The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1186%2F1479-5876-5-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FptVKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=6&author=H.+M.+Klugerauthor=M.+M.+McCarthyauthor=A.+B.+Alveroauthor=M.+Sznolauthor=S.+Ariyanauthor=R.+L.+Campauthor=D.+L.+Rimmauthor=G.+Mor&title=The+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29+is+up-regulated+in+metastatic+melanoma%2C+and+XIAP+cleavage+by+phenoxodiol+is+associated+with+carboplatin+sensitization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization</span></div><div class="casAuthors">Kluger Harriet M; McCarthy Mary M; Alvero Ayesha B; Sznol Mario; Ariyan Stephan; Camp Robert L; Rimm David L; Mor Gil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">XIAP up-regulation is associated with chemotherapy resistance.  Phenoxodiol causes XIAP degradation and chemotherapy sensitization in ovarian cancer.  Here we assessed XIAP expression in melanomas, using tissue microarrays containing 436 melanomas and 336 nevi by a novel method of automated, quantitative analysis (AQUA).  We used S100 to define pixels as melanoma (tumor mask) within the array spot, and measured XIAP expression using Cy5-conjugated antibodies within the mask.  XIAP expression was significantly higher in melanomas than nevi (P < 0.0001), and higher in metastatic than primary lesions (P < 0.0001).  We then assessed a panel of melanoma cell lines for XIAP expression, and found high expression in all cell lines.  Three of the cell lines were assessed for Phenoxodiol and Carboplatin sensitivity; all were resistant to Carboplatin and showed variable sensitivity to Phenoxodiol.  Pre-treating Phenoxodiol sensitive cells with Phenoxodiol prior to Carboplatin resulted in XIAP degradation, associated with Carboplatin sensitization and apoptosis, whereas exposing Phenoxodiol resistant cells to Phenoxodiol resulted in less XIAP degradation and minimal Carboplatin sensitization.  We conclude that XIAP levels in clinical specimens are significantly higher in melanomas than their benign counterparts, and higher in metastatic than in primary specimens, suggesting an association with malignant progression and disease aggression.  Melanoma resistance to Carboplatin is possibly due to XIAP over-expression.  Phenoxodiol can sensitize melanoma cells to Carboplatin in vitro with corresponding XIAP degradation, although the precise target and mechanism of action of Phenoxodiol are subject to further assessment.  Targeting XIAP warrants additional investigation as a therapeutic approach for metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ00ycMsdB7xlw2ofyr07jXfW6udTcc2eYvZUyOXalBp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FptVKhuw%253D%253D&md5=554ff553eaef6ecb1af8fae4ee04e365</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-5-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-5-6%26sid%3Dliteratum%253Aachs%26aulast%3DKluger%26aufirst%3DH.%2BM.%26aulast%3DMcCarthy%26aufirst%3DM.%2BM.%26aulast%3DAlvero%26aufirst%3DA.%2BB.%26aulast%3DSznol%26aufirst%3DM.%26aulast%3DAriyan%26aufirst%3DS.%26aulast%3DCamp%26aufirst%3DR.%2BL.%26aulast%3DRimm%26aufirst%3DD.%2BL.%26aulast%3DMor%26aufirst%3DG.%26atitle%3DThe%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%2520is%2520up-regulated%2520in%2520metastatic%2520melanoma%252C%2520and%2520XIAP%2520cleavage%2520by%2520phenoxodiol%2520is%2520associated%2520with%2520carboplatin%2520sensitization%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2007%26volume%3D5%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mizutani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukimura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawauchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, T.</span><span> </span><span class="NLM_article-title">Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=17332931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1WhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=919-925&author=Y.+Mizutaniauthor=H.+Nakanishiauthor=Y.+N.+Liauthor=H.+Matsubaraauthor=K.+Yamamotoauthor=N.+Satoauthor=T.+Shiraishiauthor=T.+Nakamuraauthor=K.+Mikamiauthor=K.+Okiharaauthor=N.+Takahaauthor=O.+Ukimuraauthor=A.+Kawauchiauthor=N.+Nonomuraauthor=B.+Bonavidaauthor=T.+Miki&title=Overexpression+of+XIAP+expression+in+renal+cell+carcinoma+predicts+a+worse+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis</span></div><div class="casAuthors">Mizutani, Yoichi; Nakanishi, Hiroyuki; Li, Yong Nan; Matsubara, Hiroki; Yamamoto, Kosuke; Sato, Nodoka; Shiraishi, Takumi; Nakamura, Terukazu; Mikami, Kazuya; Okihara, Koji; Takaha, Natsuki; Ukimura, Osamu; Kawauchi, Akihiro; Nonomura, Norio; Bonavida, Benjamin; Miki, Tsuneharu</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">919-925</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">X-linked inhibitor of apoptosis protein (XIAP) is the most potent caspase-inhibitory IAP family member and a neg. regulator of various apoptotic stimuli.  Thus, XIAP overexpression in cancer cells may select for tumor cell survival following various cytotoxic therapeutic modalities.  The anatomical staging system in renal cell carcinoma (RCC) currently provides good prognostic information, albeit insufficient.  We hypothesize that overexpression of XIAP in RCC may serve as a mol. prognostic marker in RCC and improve the staging of RCC.  This study examd. the protein level of XIAP in lysates from surgical specimens of 109 patients with RCC and 109 normal kidney specimens from the same patients.  The level of XIAP expression was quantified by Western blot anal. using non-fixed fresh frozen tissues of RCCs and normal kidneys.  Results indicated that the mean level of XIAP expression was higher in RCC compared to autologous normal kidney, and the XIAP expression level in 38/109 (35%) of RCC was more than 2-fold greater than that in normal kidney tissue.  In Stage I/II RCC, the mean XIAP expression level was almost identical to that detected in normal kidney, whereas XIAP expression in Stage III/IV was 2.5-fold higher than that in Stage I/II RCC.  Levels of XIAP expression also correlated with the grade of RCC.  Patients with RCC with low XIAP expression had a longer postoperative disease-specific survival as compared to those with high expression in the 5-yr follow-up.  The suggested role of XIAP in the regulation of resistance in apoptosis was examd. in vitro following treatment of RCC cell lines with XIAP antisense oligonucleotide and the cells were sensitized to both Fas-mediated and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis.  The present study demonstrates at the protein level that XIAP is overexpressed in RCC, and that high XIAP expression in RCC predicted a worse prognosis.  In addn., XIAP antisense oligonucleotide sensitized RCC to Fas/TRAIL-induced apoptosis.  These results suggest that XIAP expression in RCC may be used as a prognostic parameter, and that downregulation or inhibition of XIAP expression in RCC may reverse immune resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpmszQw07lrVg90H21EOLACvtfcHk0lge3U-6b0QERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1WhtLs%253D&md5=ec34df06bcd09c4d2e95e6116dd967d2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DY.%26aulast%3DNakanishi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%2BN.%26aulast%3DMatsubara%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMikami%26aufirst%3DK.%26aulast%3DOkihara%26aufirst%3DK.%26aulast%3DTakaha%26aufirst%3DN.%26aulast%3DUkimura%26aufirst%3DO.%26aulast%3DKawauchi%26aufirst%3DA.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DMiki%26aufirst%3DT.%26atitle%3DOverexpression%2520of%2520XIAP%2520expression%2520in%2520renal%2520cell%2520carcinoma%2520predicts%2520a%2520worse%2520prognosis%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2007%26volume%3D30%26spage%3D919%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Miller, L. K.</span><span> </span><span class="NLM_article-title">An exegesis of IAPs: salvation and surprises from BIR motifs</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2FS0962-8924%2899%2901609-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10407412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADyaK1MXltFyjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=323-328&author=L.+K.+Miller&title=An+exegesis+of+IAPs%3A+salvation+and+surprises+from+BIR+motifs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An exegesis of IAPs: salvation and surprises from BIR motifs</span></div><div class="casAuthors">Miller, Lois K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">323-328</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with ∼43 refs.  The BIR (baculovirus IAP repeat) motif is a conserved sequence of approx. 70 amino acids that was identified originally in the "inhibitor of apoptosis" (IAP) family of proteins.  BIR-contg. proteins (BIRPs) are found in viruses, yeast and metazoans.  Recent genetic anal. of a nematode BIRP demonstrated an essential role in cytokinesis instead of apoptosis.  It is likely that BIRs originated in eukaryotes to serve a role in cytokinesis and/or mitotic spindle function during cell division and that, with gene duplication, the more recent adaptation of some BIRPs to the regulation of apoptosis was possible.  IAPs interact with a variety of proteins, including members of the caspase protease family.  This article discusses current research on the structure and function of the BIR motifs and how it could provide insight into the function of BIRPs in cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkv-DdasIG5LVg90H21EOLACvtfcHk0lge3U-6b0QERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFyjtbs%253D&md5=91ae24d1acce1bc163d2c5514391f2e1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2899%2901609-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252899%252901609-8%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BK.%26atitle%3DAn%2520exegesis%2520of%2520IAPs%253A%2520salvation%2520and%2520surprises%2520from%2520BIR%2520motifs%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1999%26volume%3D9%26spage%3D323%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Cytochrome C-Mediated Apoptosis</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1146%2Fannurev.biochem.73.011303.073706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=15189137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=87-106&author=X.+Jiangauthor=X.+Wang&title=Cytochrome+C-Mediated+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome C-mediated apoptosis</span></div><div class="casAuthors">Jiang, Xuejun; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-106</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Apoptosis, or programmed cell death, is involved in development, elimination of damaged cells, and maintenance of cell homeostasis.  Deregulation of apoptosis may cause diseases, such as cancers, immune diseases, and neurodegenerative disorders.  Apoptosis is executed by a subfamily of cysteine proteases known as caspases.  In mammalian cells, a major caspase activation pathway is the cytochrome c-initiated pathway.  In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochem. reactions that result in caspase activation and subsequent cell death.  This review focused on the recent progress in understanding the biochem. mechanisms and regulation of the pathway, the roles of the pathway in physiol. and disease, and their potential therapeutic values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaXd15zPESYLVg90H21EOLACvtfcHk0lhPg_8bP_L9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D&md5=a8e668a41a4b4d0994a128019967f28d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073706%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DCytochrome%2520C-Mediated%2520Apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D87%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ashkenazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span> </span><span class="NLM_article-title">Death Receptors: Signaling and Modulation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1126%2Fscience.281.5381.1305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=9721089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1305-1308&author=A.+Ashkenaziauthor=V.+M.+Dixit&title=Death+Receptors%3A+Signaling+and+Modulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Death receptors: Signaling and modulation</span></div><div class="casAuthors">Ashkenazi, Avi; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5381</span>),
    <span class="NLM_cas:pages">1305-1308</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 61 refs.  Apoptosis is a cell suicide mechanism that enables metazoans to control cell no. in tissues and to eliminate individual cells that threaten the animal's survival.  Certain cells have unique sensors, termed death receptors, on their surface.  Death receptors detect the presence of extracellular death signals and, in response, they rapidly ignite the cell's intrinsic apoptosis machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5qJid4f9QLVg90H21EOLACvtfcHk0lhPg_8bP_L9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D&md5=9bd9f0e6b358e7cfa3b509dec7fbbe8f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5381.1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5381.1305%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DDeath%2520Receptors%253A%2520Signaling%2520and%2520Modulation%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1305%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fuentes-Prior, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span> </span><span class="NLM_article-title">The protein structures that shape caspase activity, specificity, activation and inhibition</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1042%2FBJ20041142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=15450003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSqs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2004&pages=201-232&author=P.+Fuentes-Priorauthor=G.+S.+Salvesen&title=The+protein+structures+that+shape+caspase+activity%2C+specificity%2C+activation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The protein structures that shape caspase activity, specificity, activation and inhibition</span></div><div class="casAuthors">Fuentes-Prior, Pablo; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-232</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The death morphol. commonly known as apoptosis results from a post-translational pathway driven largely by specific limited proteolysis.  In the last decade the structural basis for apoptosis regulation has moved from nothing to 'quite good', and we now know the fundamental structures of examples from the initiator phase, the pre-mitochondrial regulator phase, the executioner phase, inhibitors and their antagonists, and even the structures of some substrates.  The field is as well advanced as the best known of proteolytic pathways, the coagulation cascade.  Fundamentally new mechanisms in protease regulation have been disclosed.  Structural evidence suggests that caspases have an unusual catalytic mechanism, and that they are activated by apparently unrelated events, depending on which position in the apoptotic pathway they occupy.  Some naturally occurring caspase inhibitors have adopted classic inhibition strategies, but other have revealed completely novel mechanisms.  All of the structural and mechanistic information can, and is, being applied to drive therapeutic strategies to combat overactivation of apoptosis in degenerative disease, and underactivation in neoplasia.  We present a comprehensive review of the caspases, their regulators and inhibitors from a structural and mechanistic point of view, and with an aim to consolidate the many threads that define the rapid growth of this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowJ7v8n99EJrVg90H21EOLACvtfcHk0lhPg_8bP_L9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSqs7rP&md5=b3c9b22933c76e89ee5fa993e9ec2247</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBJ20041142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20041142%26sid%3Dliteratum%253Aachs%26aulast%3DFuentes-Prior%26aufirst%3DP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DThe%2520protein%2520structures%2520that%2520shape%2520caspase%2520activity%252C%2520specificity%252C%2520activation%2520and%2520inhibition%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D384%26spage%3D201%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Eckelman, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, F. L.</span><span> </span><span class="NLM_article-title">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2Fsj.embor.7400795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=17016456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=988-994&author=B.+P.+Eckelmanauthor=G.+S.+Salvesenauthor=F.+L.+Scott&title=Human+inhibitor+of+apoptosis+proteins%3A+why+XIAP+is+the+black+sheep+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.; Scott, Fiona L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-994</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several of the inhibitor of apoptosis protein (IAP) family members regulate apoptosis in response to various cellular assaults.  Some members are also involved in cell signaling, mitosis and targeting proteins to the ubiquitin-proteasome degrdn. machinery.  The most intensively studied family member, X-linked IAP (XIAP), is a potent inhibitor of caspase activity; hence, it is generally assumed that direct caspase inhibition is an important conserved function of most members of the family.  Biochem. and structural studies have precisely mapped the elements of XIAP required for caspase inhibition.  Intriguingly, these elements are not conserved among IAPs.  Here, we review current knowledge of the caspase-inhibitory potential of the human IAPs and show that XIAP is probably the only bona fide caspase inhibitor, suggesting that the other family members never gained the ability to directly inhibit caspase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2WCkDI8Vs7Vg90H21EOLACvtfcHk0lhPg_8bP_L9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K&md5=7db7a68e171e0303dd25ba6e2a97be34</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400795%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DScott%26aufirst%3DF.%2BL.%26atitle%3DHuman%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520why%2520XIAP%2520is%2520the%2520black%2520sheep%2520of%2520the%2520family%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D988%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Smac, a Mitochondrial Protein that Promotes Cytochrome c-Dependent Caspase Activation by Eliminating IAP Inhibition</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2FS0092-8674%2800%2900008-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10929711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=33-42&author=C.+Duauthor=M.+Fangauthor=Y.+Liauthor=L.+Liauthor=X.+Wang&title=Smac%2C+a+Mitochondrial+Protein+that+Promotes+Cytochrome+c-Dependent+Caspase+Activation+by+Eliminating+IAP+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span></div><div class="casAuthors">Du, Chunying; Fang, Min; Li, Yucheng; Li, Lily; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway.  Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity.  Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis.  Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity.  Overexpression of Smac increases cells' sensitivity to apoptotic stimuli.  Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUyaGmAsnprVg90H21EOLACvtfcHk0lhBE2Po7nfQjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D&md5=8321d44bed77ff7c2da398e1b02f9e20</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900008-8%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSmac%252C%2520a%2520Mitochondrial%2520Protein%2520that%2520Promotes%2520Cytochrome%2520c-Dependent%2520Caspase%2520Activation%2520by%2520Eliminating%2520IAP%2520Inhibition%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D33%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verhagen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekert, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pakusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span> </span><span class="NLM_article-title">Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2FS0092-8674%2800%2900009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10929712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=43-53&author=A.+M.+Verhagenauthor=P.+G.+Ekertauthor=M.+Pakuschauthor=J.+Silkeauthor=L.+M.+Connollyauthor=G.+E.+Reidauthor=R.+L.+Moritzauthor=R.+J.+Simpsonauthor=D.+L.+Vaux&title=Identification+of+DIABLO%2C+a+Mammalian+Protein+that+Promotes+Apoptosis+by+Binding+to+and+Antagonizing+IAP+Proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span></div><div class="casAuthors">Verhagen, Anne M.; Ekert, Paul G.; Pakusch, Miha; Silke, John; Connolly, Lisa M.; Reid, Gavin E.; Moritz, Robert L.; Simpson, Richard J.; Vaux, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunopptn. and 2D immobilized pH gradient/SDS-PAGE, followed by electrospray ionization tandem mass spectrometry.  DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP.  The N-terminally processed, IAP-interacting form of DIABLO is concd. in membrane fractions in healthy cells but released into the MIHA-contg. cytosolic fractions upon UV irradn.  As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradn., DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-TYWHjxeE7Vg90H21EOLACvtfcHk0lhBE2Po7nfQjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D&md5=475519bd43e9d625b06b0293895d9693</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900009-X%26sid%3Dliteratum%253Aachs%26aulast%3DVerhagen%26aufirst%3DA.%2BM.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DPakusch%26aufirst%3DM.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DL.%2BM.%26aulast%3DReid%26aufirst%3DG.%2BE.%26aulast%3DMoritz%26aufirst%3DR.%2BL.%26aulast%3DSimpson%26aufirst%3DR.%2BJ.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520DIABLO%252C%2520a%2520Mammalian%2520Protein%2520that%2520Promotes%2520Apoptosis%2520by%2520Binding%2520to%2520and%2520Antagonizing%2520IAP%2520Proteins%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suber, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of IAP recognition by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.-W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0lhBE2Po7nfQjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+Smac%2FDIABLO+to+the+XIAP+BIR3+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third β-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0lhwdNElKRnQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520Smac%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">In addition to the molecules specifically mentioned in this paper, other monovalent XIAP inhibitors have been reported, as well as bivalent inhibitors such as AEG40826/HGS1029, which has also entered the clinic. For further discussion, see ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+Potent+and+Orally+Active+Antagonist+%28SM-406%2FAT-406%29+of+Multiple+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+in+Clinical+Development+for+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0lhwdNElKRnQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Active%2520Antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520in%2520Clinical%2520Development%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4101</span><span class="NLM_x">–</span> <span class="NLM_lpage">4113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&author=J.+A.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.-P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+A.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+Potent+Small-Molecule+Antagonist+of+Inhibitor+of+Apoptosis+%28IAP%29+Proteins+and+Clinical+Candidate+for+the+Treatment+of+Cancer+%28GDC-0152%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 ± 3 mL/min/kg, and the vol. of distribution was 0.6 ± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0ljkpfJhsf__4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.-P.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Small-Molecule%2520Antagonist%2520of%2520Inhibitor%2520of%2520Apoptosis%2520%2528IAP%2529%2520Proteins%2520and%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4101%26epage%3D4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carol, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billups, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program</span> <span class="citation_source-journal">Pediatr. Blood Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1002%2Fpbc.23167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=636-639&author=P.+J.+Houghtonauthor=M.+H.+Kangauthor=C.+P.+Reynoldsauthor=C.+L.+Mortonauthor=E.+A.+Kolbauthor=R.+Gorlickauthor=S.+T.+Keirauthor=H.+Carolauthor=R.+Lockauthor=J.+M.+Marisauthor=C.+A.+Billupsauthor=M.+A.+Smith&title=Initial+Testing+%28Stage+1%29+of+LCL161%2C+a+SMAC+Mimetic%2C+by+the+Pediatric+Preclinical+Testing+Program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program</span></div><div class="casAuthors">Houghton Peter J; Kang Min H; Reynolds C Patrick; Morton Christopher L; Kolb E Anders; Gorlick Richard; Keir Stephen T; Carol Hernan; Lock Richard; Maris John M; Billups Catherine A; Smith Malcolm A</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric blood & cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 μM) and the PPTP in vivo panels (30 or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice in a week.  LCL161 showed a median relative IC(50) value of >10 μM, being more potent against several leukemia and lymphoma lines.  In vivo LCL161 induced significant differences in EFS distribution in approximately one-third of solid tumor xenografts (osteosarcoma and glioblastoma), but not in ALL xenografts.  No objective tumor responses were observed.  In vivo LCL161 demonstrated limited single agent activity against the pediatric preclinical models studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSUatUzOMj4MULxIEhxUjPfW6udTcc2eaSNL-9pMjUjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D&md5=39302864067c6f9d1bfc9fca041d6c3c</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1002%2Fpbc.23167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.23167%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DKang%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DMorton%26aufirst%3DC.%2BL.%26aulast%3DKolb%26aufirst%3DE.%2BA.%26aulast%3DGorlick%26aufirst%3DR.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DCarol%26aufirst%3DH.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DBillups%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DInitial%2520Testing%2520%2528Stage%25201%2529%2520of%2520LCL161%252C%2520a%2520SMAC%2520Mimetic%252C%2520by%2520the%2520Pediatric%2520Preclinical%2520Testing%2520Program%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2012%26volume%3D58%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, K.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.-L.</span><span> </span><span class="NLM_article-title">Inhibition of Bcl-2 improves effect of LCL 161, a SMAC, mimetic in hepatocellular carcinoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=268-277&author=K.-F.+Chenauthor=J.-P.+Linauthor=C.-W.+Shiauauthor=W.-T.+Taiauthor=C.-Y.+Liuauthor=H.-C.+Yuauthor=P.-J.+Chenauthor=A.-L.+Cheng&title=Inhibition+of+Bcl-2+improves+effect+of+LCL+161%2C+a+SMAC%2C+mimetic+in+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.-F.%26aulast%3DLin%26aufirst%3DJ.-P.%26aulast%3DShiau%26aufirst%3DC.-W.%26aulast%3DTai%26aufirst%3DW.-T.%26aulast%3DLiu%26aufirst%3DC.-Y.%26aulast%3DYu%26aufirst%3DH.-C.%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DCheng%26aufirst%3DA.-L.%26atitle%3DInhibition%2520of%2520Bcl-2%2520improves%2520effect%2520of%2520LCL%2520161%252C%2520a%2520SMAC%252C%2520mimetic%2520in%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D268%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-123&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-C.</span><span> </span><span class="NLM_article-title">Smac Mimetics and TNFα: A Dangerous Liaison?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=655-658&author=H.+Wuauthor=J.+Tschoppauthor=S.-C.+Lin&title=Smac+Mimetics+and+TNF%CE%B1%3A+A+Dangerous+Liaison%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DTschopp%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DS.-C.%26atitle%3DSmac%2520Mimetics%2520and%2520TNF%25CE%25B1%253A%2520A%2520Dangerous%2520Liaison%253F%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D655%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Gonzalez-Lopez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriete, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">–</span> <span class="NLM_lpage">4336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2Fj.bmcl.2011.05.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=21680182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4332-4336&author=M.+Gonzalez-Lopezauthor=K.+Welshauthor=D.+Finlayauthor=R.+J.+Ardeckyauthor=S.+R.+Ganjiauthor=Y.+Suauthor=H.+Yuanauthor=P.+Terieteauthor=P.+D.+Maceauthor=S.+J.+Riedlauthor=K.+Vuoriauthor=J.+C.+Reedauthor=N.+D.+P.+Cosford&title=Design%2C+synthesis+and+evaluation+of+monovalent+Smac+mimetics+that+bind+to+the+BIR2+domain+of+the+anti-apoptotic+protein+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP</span></div><div class="casAuthors">Gonzalez-Lopez, Marcos; Welsh, Kate; Finlay, Darren; Ardecky, Robert J.; Ganji, Santhi Reddy; Su, Ying; Yuan, Hongbin; Teriete, Peter; Mace, Peter D.; Riedl, Stefan J.; Vuori, Kristiina; Reed, John C.; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4332-4336</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein is reported the systematic rational design and synthesis of new monovalent Smac mimetics that bind preferentially to the BIR2 domain of the anti-apoptotic protein XIAP.  Characterization of compds. in vitro (including I; ML101) led to the detn. of key structural requirements for BIR2 binding affinity.  Compds. II and III sensitized TRAIL-resistant breast cancer cells to apoptotic cell death, highlighting the value of these probe compds. as tools to investigate the biol. of XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbRdeoMcYXrVg90H21EOLACvtfcHk0liesUBADyJeNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWrtrg%253D&md5=c5b3ba8d8e84accb61d9a157972791da</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.049%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%26aufirst%3DM.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DFinlay%26aufirst%3DD.%26aulast%3DArdecky%26aufirst%3DR.%2BJ.%26aulast%3DGanji%26aufirst%3DS.%2BR.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DTeriete%26aufirst%3DP.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520monovalent%2520Smac%2520mimetics%2520that%2520bind%2520to%2520the%2520BIR2%2520domain%2520of%2520the%2520anti-apoptotic%2520protein%2520XIAP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4332%26epage%3D4336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Donnell, A. F.; Michoud, C.; Rupert, K. C.; Han, X.; Aguilar, D.; Frank, K. B.; Fretland, A. J.; Gao, L.; Goggin, B.; Hogg, J. H.; Hong, K.; Janson, C. A.; Kester, R. F.; Kong, N.; Le, K.; Li, S.; Liang, W.; Lombardo, L. J.; Lou, Y.; Lukacs, C.; Mischke, S.; Moliterni, J. A.; Polonskaia, A.; Schutt, A. D.; Solis, D. S.; Specian, A.; Taylor, R. T.; Weisel, M.; Remiszewski, S. W.</span><span> </span><span class="NLM_article-title">Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1021/jm400731m</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400731m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+F.+Donnell&author=C.+Michoud&author=K.+C.+Rupert&author=X.+Han&author=D.+Aguilar&author=K.+B.+Frank&author=A.+J.+Fretland&author=L.+Gao&author=B.+Goggin&author=J.+H.+Hogg&author=K.+Hong&author=C.+A.+Janson&author=R.+F.+Kester&author=N.+Kong&author=K.+Le&author=S.+Li&author=W.+Liang&author=L.+J.+Lombardo&author=Y.+Lou&author=C.+Lukacs&author=S.+Mischke&author=J.+A.+Moliterni&author=A.+Polonskaia&author=A.+D.+Schutt&author=D.+S.+Solis&author=A.+Specian&author=R.+T.+Taylor&author=M.+Weisel&author=S.+W.+Remiszewski&title=Benzazepinones+and+Benzoxazepinones+as+Antagonists+of+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+Selective+for+the+Second+Baculovirus+IAP+Repeat+%28BIR2%29+Domain&doi=10.1021%2Fjm400731m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400731m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400731m%26sid%3Dliteratum%253Aachs%26aulast%3DDonnell%26aufirst%3DA.%2BF.%26atitle%3DBenzazepinones%2520and%2520Benzoxazepinones%2520as%2520Antagonists%2520of%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520Selective%2520for%2520the%2520Second%2520Baculovirus%2520IAP%2520Repeat%2520%2528BIR2%2529%2520Domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400731m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Schutt, A.; Goggin, B. S.; Hong, K.; Polonskaia, A.; To, T.; Tardell, C.; Dvorozniak, M.; Tannu, S.; Aguilar, D.; Solis, D.; Gao, L.; Lukacs, C.; Jansen, G.; Hilton, H.; Fretland, A.; Liang, Z.; Lee, K.; Kester, R.; Donnell, A.; Mischke, S.; Han, X.; Chen, S.; Le, N.; Lou, Y.; Remiszewski, S.; Packman, K.; Lee, E. C.</span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schutt%2C+A.%3B+Goggin%2C+B.+S.%3B+Hong%2C+K.%3B+Polonskaia%2C+A.%3B+To%2C+T.%3B+Tardell%2C+C.%3B+Dvorozniak%2C+M.%3B+Tannu%2C+S.%3B+Aguilar%2C+D.%3B+Solis%2C+D.%3B+Gao%2C+L.%3B+Lukacs%2C+C.%3B+Jansen%2C+G.%3B+Hilton%2C+H.%3B+Fretland%2C+A.%3B+Liang%2C+Z.%3B+Lee%2C+K.%3B+Kester%2C+R.%3B+Donnell%2C+A.%3B+Mischke%2C+S.%3B+Han%2C+X.%3B+Chen%2C+S.%3B+Le%2C+N.%3B+Lou%2C+Y.%3B+Remiszewski%2C+S.%3B+Packman%2C+K.%3B+Lee%2C+E.+C.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSchutt%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lauffer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullican, M. D.</span><span> </span><span class="NLM_article-title">A Practical Synthesis of (<i>S</i>) 3-<i>tert</i>-Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic Acid Methyl Ester as a Conformationally Restricted Dipeptido-Mimetic for Caspase-1 (ICE) Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1225-1227&author=D.+J.+Laufferauthor=M.+D.+Mullican&title=A+Practical+Synthesis+of+%28S%29+3-tert-Butoxycarbonylamino-2-oxo-2%2C3%2C4%2C5-tetrahydro-1%2C5-benzodiazepine-1-acetic+Acid+Methyl+Ester+as+a+Conformationally+Restricted+Dipeptido-Mimetic+for+Caspase-1+%28ICE%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauffer%26aufirst%3DD.%2BJ.%26aulast%3DMullican%26aufirst%3DM.%2BD.%26atitle%3DA%2520Practical%2520Synthesis%2520of%2520%2528S%2529%25203-tert-Butoxycarbonylamino-2-oxo-2%252C3%252C4%252C5-tetrahydro-1%252C5-benzodiazepine-1-acetic%2520Acid%2520Methyl%2520Ester%2520as%2520a%2520Conformationally%2520Restricted%2520Dipeptido-Mimetic%2520for%2520Caspase-1%2520%2528ICE%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1225%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lukacs, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belunis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowhter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danho, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remiszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">The Crystal Structure of XIAP-BIR2: Understanding selectivity of the BIR domains</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D.: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1717-1725&author=C.+M.+Lukacsauthor=C.+Belunisauthor=R.+Crowhterauthor=W.+Danhoauthor=L.+Gaoauthor=B.+Gogginauthor=C.+A.+Jansonauthor=S.+Liauthor=S.+Remiszewskiauthor=A.+Schuttauthor=M.+K.+Thakurauthor=S.+K.+Singhauthor=S.+Swaminathanauthor=R.+Pandeyauthor=R.+Tyagiauthor=R.+Gosuauthor=A.+V.+Kamathauthor=A.+Kuglstatter&title=The+Crystal+Structure+of+XIAP-BIR2%3A+Understanding+selectivity+of+the+BIR+domains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukacs%26aufirst%3DC.%2BM.%26aulast%3DBelunis%26aufirst%3DC.%26aulast%3DCrowhter%26aufirst%3DR.%26aulast%3DDanho%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRemiszewski%26aufirst%3DS.%26aulast%3DSchutt%26aufirst%3DA.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DR.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520Crystal%2520Structure%2520of%2520XIAP-BIR2%253A%2520Understanding%2520selectivity%2520of%2520the%2520BIR%2520domains%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D.%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1717%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Dobler, M. R.; Lenoir, F.; Parker, D. T.; Peng, Y.; Piizzi, G.; Wattanasin, S.</span><span> </span><span class="NLM_article-title">Organic Compounds for Application in Bacterial Infection Treatment</span>. PCT International Application PCT/EP2009/061905,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+R.+Dobler&author=F.+Lenoir&author=D.+T.+Parker&author=Y.+Peng&author=G.+Piizzi&author=S.+Wattanasin&title=Organic+Compounds+for+Application+in+Bacterial+Infection+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDobler%26aufirst%3DM.%2BR.%26atitle%3DOrganic%2520Compounds%2520for%2520Application%2520in%2520Bacterial%2520Infection%2520Treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretland, A. J.</span><span> </span><span class="NLM_article-title">Determination of Time-Dependent Inactivation of CYP3A4 in Cryopreserved Human Hepatocyctes and Assessment of Human Drug-Drug Interactions</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=2085-2092&author=Y.+Chenauthor=L.+Liuauthor=M.+Monshouwerauthor=A.+J.+Fretland&title=Determination+of+Time-Dependent+Inactivation+of+CYP3A4+in+Cryopreserved+Human+Hepatocyctes+and+Assessment+of+Human+Drug-Drug+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMonshouwer%26aufirst%3DM.%26aulast%3DFretland%26aufirst%3DA.%2BJ.%26atitle%3DDetermination%2520of%2520Time-Dependent%2520Inactivation%2520of%2520CYP3A4%2520in%2520Cryopreserved%2520Human%2520Hepatocyctes%2520and%2520Assessment%2520of%2520Human%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D2085%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gaither, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borawski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slisz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iourgenko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawel, L.</span><span> </span><span class="NLM_article-title">A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11493</span><span class="NLM_x">–</span> <span class="NLM_lpage">11498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11493-11498&author=A.+Gaitherauthor=D.+Porterauthor=Y.+Yaoauthor=J.+Borawskiauthor=G.+Yangauthor=J.+Donovanauthor=D.+Sageauthor=J.+Sliszauthor=M.+Tranauthor=C.+Straubauthor=T.+Ramseyauthor=V.+Iourgenkoauthor=A.+Huangauthor=Y.+Chenauthor=R.+Schlegelauthor=M.+Labowauthor=S.+Fawellauthor=W.+R.+Sellersauthor=L.+Zawel&title=A+Smac+Mimetic+Rescue+Screen+Reveals+Roles+for+Inhibitor+of+Apoptosis+Proteins+in+Tumor+Necrosis+Factor-%CE%B1+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaither%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DBorawski%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DSage%26aufirst%3DD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DIourgenko%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DLabow%26aufirst%3DM.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DZawel%26aufirst%3DL.%26atitle%3DA%2520Smac%2520Mimetic%2520Rescue%2520Screen%2520Reveals%2520Roles%2520for%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520in%2520Tumor%2520Necrosis%2520Factor-%25CE%25B1%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D11493%26epage%3D11498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.-H.+Zhangauthor=T.+D.+Y.+Chungauthor=K.+R.+Oldenburg&title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eZFWDANR5fRd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520Simple%2520Statistical%2520Parameter%2520for%2520Use%2520in%2520Evaluation%2520and%2520Validation%2520of%2520High%2520Throughput%2520Screening%2520Assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':[],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Willem den Besten, Kshitij Verma, Sayumi Yamazoe, Nicole Blaquiere, Wilson Phung, Anita Izrael-Tomasevic, Melinda M. Mulvihill, Elizabeth Helgason, Sumit Prakash, Tatiana Goncharov, Domagoj Vucic, Erin Dueber, Wayne J. Fairbrother, Ingrid Wertz, Kebing Yu, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Primary Amine Tethered Small Molecules Promote the Degradation of X-Linked Inhibitor of Apoptosis Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (28)
                                     , 10571-10575. <a href="https://doi.org/10.1021/jacs.1c05269" title="DOI URL">https://doi.org/10.1021/jacs.1c05269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c05269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c05269%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPrimary%252BAmine%252BTethered%252BSmall%252BMolecules%252BPromote%252Bthe%252BDegradation%252Bof%252BX-Linked%252BInhibitor%252Bof%252BApoptosis%252BProtein%26aulast%3DBesten%26aufirst%3DWillem%2Bden%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26052021%26date%3D08072021%26volume%3D143%26issue%3D28%26spage%3D10571%26epage%3D10575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicole Blaquiere, Elisia Villemure, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 7957-7985. <a href="https://doi.org/10.1021/acs.jmedchem.9b01451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252Bof%252BInhibiting%252BRING-Type%252BE3%252BUbiquitin%252BLigases%26aulast%3DBlaquiere%26aufirst%3DNicole%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31082019%26date%3D02042020%26date%3D06032020%26volume%3D63%26issue%3D15%26spage%3D7957%26epage%3D7985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui Cong, Lijuan Xu, Yougen Wu, Zhuo Qu, Tengfei Bian, Wannian Zhang, Chengguo Xing, <span class="NLM_string-name hlFld-ContribAuthor">Chunlin Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5750-5772. <a href="https://doi.org/10.1021/acs.jmedchem.8b01668" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01668%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitor%252Bof%252BApoptosis%252BProtein%252B%252528IAP%252529%252BAntagonists%252Bin%252BAnticancer%252BAgent%252BDiscovery%25253A%252BCurrent%252BStatus%252Band%252BPerspectives%26aulast%3DCong%26aufirst%3DHui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27102018%26date%3D01022019%26date%3D24012019%26volume%3D62%26issue%3D12%26spage%3D5750%26epage%3D5772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Ildiko M.  Buck</span>, <span class="hlFld-ContribAuthor ">James E. H.  Day</span>, <span class="hlFld-ContribAuthor ">Philip J.  Day</span>, <span class="hlFld-ContribAuthor ">Aman  Iqbal</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Johnson</span>, <span class="hlFld-ContribAuthor ">Edward J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Vanessa  Martins</span>, <span class="hlFld-ContribAuthor ">Darcey  Miller</span>, <span class="hlFld-ContribAuthor ">Michael  Reader</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Sharna J.  Rich</span>, <span class="hlFld-ContribAuthor ">Emiliano  Tamanini</span>, <span class="hlFld-ContribAuthor ">Marc  Vitorino</span>, <span class="hlFld-ContribAuthor ">George A.  Ward</span>, <span class="hlFld-ContribAuthor ">Pamela A.  Williams</span>, <span class="hlFld-ContribAuthor ">Glyn  Williams</span>, <span class="hlFld-ContribAuthor ">Nicola E.  Wilsher</span>, and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6574-6588. <a href="https://doi.org/10.1021/acs.jmedchem.5b00706" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00706%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDrug%252BDiscovery%252BTargeting%252BInhibitor%252Bof%252BApoptosis%252BProteins%25253A%252BDiscovery%252Bof%252Ba%252BNon-Alanine%252BLead%252BSeries%252Bwith%252BDual%252BActivity%252BAgainst%252BcIAP1%252Band%252BXIAP%26aulast%3DChessari%26aufirst%3DGianni%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07052015%26date%3D07082015%26date%3D27082015%26date%3D28072015%26volume%3D58%26issue%3D16%26spage%3D6574%26epage%3D6588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew F.  Donnell</span>, <span class="hlFld-ContribAuthor ">Christophe  Michoud</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  Rupert</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Han</span>, <span class="hlFld-ContribAuthor ">Douglas  Aguilar</span>, <span class="hlFld-ContribAuthor ">Karl B.  Frank</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Fretland</span>, <span class="hlFld-ContribAuthor ">Lin  Gao</span>, <span class="hlFld-ContribAuthor ">Barry  Goggin</span>, <span class="hlFld-ContribAuthor ">J. Heather  Hogg</span>, <span class="hlFld-ContribAuthor ">Kyoungja  Hong</span>, <span class="hlFld-ContribAuthor ">Cheryl A.  Janson</span>, <span class="hlFld-ContribAuthor ">Robert F.  Kester</span>, <span class="hlFld-ContribAuthor ">Norman  Kong</span>, <span class="hlFld-ContribAuthor ">Kang  Le</span>, <span class="hlFld-ContribAuthor ">Shirley  Li</span>, <span class="hlFld-ContribAuthor ">Weiling  Liang</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Yan  Lou</span>, <span class="hlFld-ContribAuthor ">Christine M.  Lukacs</span>, <span class="hlFld-ContribAuthor ">Steven  Mischke</span>, <span class="hlFld-ContribAuthor ">John A.  Moliterni</span>, <span class="hlFld-ContribAuthor ">Ann  Polonskaia</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Schutt</span>, <span class="hlFld-ContribAuthor ">Dave S.  Solis</span>, <span class="hlFld-ContribAuthor ">Anthony  Specian</span>, <span class="hlFld-ContribAuthor ">Robert T.  Taylor</span>, <span class="hlFld-ContribAuthor ">Martin  Weisel</span>, and <span class="hlFld-ContribAuthor ">Stacy W.  Remiszewski</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7772-7787. <a href="https://doi.org/10.1021/jm400731m" title="DOI URL">https://doi.org/10.1021/jm400731m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400731m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400731m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzazepinones%252Band%252BBenzoxazepinones%252Bas%252BAntagonists%252Bof%252BInhibitor%252Bof%252BApoptosis%252BProteins%252B%252528IAPs%252529%252BSelective%252Bfor%252Bthe%252BSecond%252BBaculovirus%252BIAP%252BRepeat%252B%252528BIR2%252529%252BDomain%26aulast%3DDonnell%26aufirst%3DAndrew%2BF.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15052013%26date%3D01102013%26date%3D24102013%26volume%3D56%26issue%3D20%26spage%3D7772%26epage%3D7787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Firoz A. Dain Md  Opo</span>, <span class="hlFld-ContribAuthor ">Mohammed M.  Rahman</span>, <span class="hlFld-ContribAuthor ">Foysal  Ahammad</span>, <span class="hlFld-ContribAuthor ">Istiak  Ahmed</span>, <span class="hlFld-ContribAuthor ">Mohiuddin Ahmed  Bhuiyan</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Asiri</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-83626-x" title="DOI URL">https://doi.org/10.1038/s41598-021-83626-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-83626-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-83626-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DStructure%252Bbased%252Bpharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%25252C%252Bmolecular%252Bdocking%252Band%252BADMET%252Bapproaches%252Bfor%252Bidentification%252Bof%252Bnatural%252Banti-cancer%252Bagents%252Btargeting%252BXIAP%252Bprotein%26aulast%3DOpo%26aufirst%3DFiroz%2BA.%2BDain%2BMd%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleša  Bricelj</span>, <span class="hlFld-ContribAuthor ">Christian  Steinebach</span>, <span class="hlFld-ContribAuthor ">Robert  Kuchta</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Izidor  Sosič</span>. </span><span class="cited-content_cbyCitation_article-title">E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.707317" title="DOI URL">https://doi.org/10.3389/fchem.2021.707317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.707317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.707317%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DE3%252BLigase%252BLigands%252Bin%252BSuccessful%252BPROTACs%25253A%252BAn%252BOverview%252Bof%252BSyntheses%252Band%252BLinker%252BAttachment%252BPoints%26aulast%3DBricelj%26aufirst%3DAle%25C5%25A1a%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng-Qing  Li</span>, <span class="hlFld-ContribAuthor ">Xiuping  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules targeting ubiquitination to control inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>116 </em><a href="https://doi.org/10.1016/j.drudis.2021.04.029" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.04.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.04.029%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSmall%252Bmolecules%252Btargeting%252Bubiquitination%252Bto%252Bcontrol%252Binflammatory%252Bdiseases%26aulast%3DLi%26aufirst%3DZheng-Qing%26date%3D2021%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damilohun Samuel  Metibemu</span>, <span class="hlFld-ContribAuthor ">Oluseyi Adeboye  Akinloye</span>, <span class="hlFld-ContribAuthor ">Adio Jamiu  Akamo</span>, <span class="hlFld-ContribAuthor ">Jude Ogechukwu  Okoye</span>, <span class="hlFld-ContribAuthor ">David Ajiboye  Ojo</span>, <span class="hlFld-ContribAuthor ">Eric  Morifi</span>, <span class="hlFld-ContribAuthor ">Idowu Olaposi  Omotuyi</span>. </span><span class="cited-content_cbyCitation_article-title">Carotenoid isolates of
              Spondias mombin
              demonstrate anticancer effects in DMBA‐induced breast cancer in Wistar rats through X‐linked inhibitor of apoptosis protein (XIAP) antagonism and anti‐inflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Biochemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (12)
                                     <a href="https://doi.org/10.1111/jfbc.13523" title="DOI URL">https://doi.org/10.1111/jfbc.13523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jfbc.13523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjfbc.13523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Biochemistry%26atitle%3DCarotenoid%252Bisolates%252Bof%252BSpondias%252Bmombin%252Bdemonstrate%252Banticancer%252Beffects%252Bin%252BDMBA%2525E2%252580%252590induced%252Bbreast%252Bcancer%252Bin%252BWistar%252Brats%252Bthrough%252BX%2525E2%252580%252590linked%252Binhibitor%252Bof%252Bapoptosis%252Bprotein%252B%252528XIAP%252529%252Bantagonism%252Band%252Banti%2525E2%252580%252590inflammation%26aulast%3DMetibemu%26aufirst%3DDamilohun%2BSamuel%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Lin</span>, <span class="hlFld-ContribAuthor ">Hua  Xiang</span>, <span class="hlFld-ContribAuthor ">Guoshun  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112689. <a href="https://doi.org/10.1016/j.ejmech.2020.112689" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112689%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bestrogen%252Breceptor%252B%2525CE%2525B1%252Bfor%252Bdegradation%252Bwith%252BPROTACs%25253A%252BA%252Bpromising%252Bapproach%252Bto%252Bovercome%252Bendocrine%252Bresistance%26aulast%3DLin%26aufirst%3DXin%26date%3D2020%26volume%3D206%26spage%3D112689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengkuan  Tang</span>, <span class="hlFld-ContribAuthor ">Yu  Zuo</span>, <span class="hlFld-ContribAuthor ">Fengmin  Xiong</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation revealed the intrinsic conformational change of cellular inhibitor of apoptosis protein-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 975-984. <a href="https://doi.org/10.1080/07391102.2019.1591303" title="DOI URL">https://doi.org/10.1080/07391102.2019.1591303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1591303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1591303%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Brevealed%252Bthe%252Bintrinsic%252Bconformational%252Bchange%252Bof%252Bcellular%252Binhibitor%252Bof%252Bapoptosis%252Bprotein-1%26aulast%3DXu%26aufirst%3DHeng%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D4%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Pragya  Adhikari</span>, <span class="hlFld-ContribAuthor ">Robert A.  Blake</span>, <span class="hlFld-ContribAuthor ">Nicole  Blaquiere</span>, <span class="hlFld-ContribAuthor ">Jinhua  Chen</span>, <span class="hlFld-ContribAuthor ">Yun-Xing  Cheng</span>, <span class="hlFld-ContribAuthor ">Willem  den Besten</span>, <span class="hlFld-ContribAuthor ">Jinping  Han</span>, <span class="hlFld-ContribAuthor ">Steven J.  Hartman</span>, <span class="hlFld-ContribAuthor ">Jintang  He</span>, <span class="hlFld-ContribAuthor ">Mingtao  He</span>, <span class="hlFld-ContribAuthor ">Ellen  Rei Ingalla</span>, <span class="hlFld-ContribAuthor ">Amrita V.  Kamath</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Tommy  Lai</span>, <span class="hlFld-ContribAuthor ">Douglas D.  Leipold</span>, <span class="hlFld-ContribAuthor ">Chun Sing  Li</span>, <span class="hlFld-ContribAuthor ">Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Jiawei  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Fanwei  Meng</span>, <span class="hlFld-ContribAuthor ">Lingyao  Meng</span>, <span class="hlFld-ContribAuthor ">Carl  Ng</span>, <span class="hlFld-ContribAuthor ">Kaishan  Peng</span>, <span class="hlFld-ContribAuthor ">Gail  Lewis Phillips</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Pillow</span>, <span class="hlFld-ContribAuthor ">Rebecca K.  Rowntree</span>, <span class="hlFld-ContribAuthor ">Jack D.  Sadowsky</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Leanna  Staben</span>, <span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Kunpeng  Wan</span>, <span class="hlFld-ContribAuthor ">Xinxin  Wang</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Ingrid E.  Wertz</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Xin</span>, <span class="hlFld-ContribAuthor ">Keyang  Xu</span>, <span class="hlFld-ContribAuthor ">Hui  Yao</span>, <span class="hlFld-ContribAuthor ">Richard  Zang</span>, <span class="hlFld-ContribAuthor ">Donglu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yongxin  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126907. <a href="https://doi.org/10.1016/j.bmcl.2019.126907" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126907%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntibody-mediated%252Bdelivery%252Bof%252Bchimeric%252Bprotein%252Bdegraders%252Bwhich%252Btarget%252Bestrogen%252Breceptor%252Balpha%252B%252528ER%2525CE%2525B1%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Benzodiazepines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 15-58. <a href="https://doi.org/10.1002/9781118686263.ch2" title="DOI URL">https://doi.org/10.1002/9781118686263.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DBenzodiazepines%26date%3D2018%26date%3D2018%26spage%3D15%26epage%3D58%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatiana  Goncharov</span>, <span class="hlFld-ContribAuthor ">Stefanie  Hedayati</span>, <span class="hlFld-ContribAuthor ">Melinda M.  Mulvihill</span>, <span class="hlFld-ContribAuthor ">Anita  Izrael-Tomasevic</span>, <span class="hlFld-ContribAuthor ">Kerry  Zobel</span>, <span class="hlFld-ContribAuthor ">Surinder  Jeet</span>, <span class="hlFld-ContribAuthor ">Anna V.  Fedorova</span>, <span class="hlFld-ContribAuthor ">Celine  Eidenschenk</span>, <span class="hlFld-ContribAuthor ">Jason  deVoss</span>, <span class="hlFld-ContribAuthor ">Kebing  Yu</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Shaw</span>, <span class="hlFld-ContribAuthor ">Donald S.  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Wayne J.  Fairbrother</span>, <span class="hlFld-ContribAuthor ">Kurt  Deshayes</span>, <span class="hlFld-ContribAuthor ">Domagoj  Vucic</span>. </span><span class="cited-content_cbyCitation_article-title">Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2018,</strong> <em>69 </em>
                                    (4)
                                     , 551-565.e7. <a href="https://doi.org/10.1016/j.molcel.2018.01.016" title="DOI URL">https://doi.org/10.1016/j.molcel.2018.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2018.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2018.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DDisruption%252Bof%252BXIAP-RIP2%252BAssociation%252BBlocks%252BNOD2-Mediated%252BInflammatory%252BSignaling%26aulast%3DGoncharov%26aufirst%3DTatiana%26date%3D2018%26volume%3D69%26issue%3D4%26spage%3D551%26epage%3D565.e7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Schwerd</span>, <span class="hlFld-ContribAuthor ">Sumeet  Pandey</span>, <span class="hlFld-ContribAuthor ">Huei-Ting  Yang</span>, <span class="hlFld-ContribAuthor ">Katrin  Bagola</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Jameson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Jung</span>, <span class="hlFld-ContribAuthor ">Robin H  Lachmann</span>, <span class="hlFld-ContribAuthor ">Neil  Shah</span>, <span class="hlFld-ContribAuthor ">Smita Y  Patel</span>, <span class="hlFld-ContribAuthor ">Claire  Booth</span>, <span class="hlFld-ContribAuthor ">Heiko  Runz</span>, <span class="hlFld-ContribAuthor ">Gesche  Düker</span>, <span class="hlFld-ContribAuthor ">Ruth  Bettels</span>, <span class="hlFld-ContribAuthor ">Marianne  Rohrbach</span>, <span class="hlFld-ContribAuthor ">Subra  Kugathasan</span>, <span class="hlFld-ContribAuthor ">Helen  Chapel</span>, <span class="hlFld-ContribAuthor ">Satish  Keshav</span>, <span class="hlFld-ContribAuthor ">Abdul  Elkadri</span>, <span class="hlFld-ContribAuthor ">Nick  Platt</span>, <span class="hlFld-ContribAuthor ">Alexio M  Muise</span>, <span class="hlFld-ContribAuthor ">Sibylle  Koletzko</span>, <span class="hlFld-ContribAuthor ">Ramnik J  Xavier</span>, <span class="hlFld-ContribAuthor ">Thorsten  Marquardt</span>, <span class="hlFld-ContribAuthor ">Fiona  Powrie</span>, <span class="hlFld-ContribAuthor ">James E  Wraith</span>, <span class="hlFld-ContribAuthor ">Mads  Gyrd-Hansen</span>, <span class="hlFld-ContribAuthor ">Frances M  Platt</span>, <span class="hlFld-ContribAuthor ">Holm H  Uhlig</span>. </span><span class="cited-content_cbyCitation_article-title">Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease. </span><span class="cited-content_cbyCitation_journal-name">Gut</span><span> <strong>2017,</strong> <em>66 </em>
                                    (6)
                                     , 1060-1073. <a href="https://doi.org/10.1136/gutjnl-2015-310382" title="DOI URL">https://doi.org/10.1136/gutjnl-2015-310382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/gutjnl-2015-310382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fgutjnl-2015-310382%26sid%3Dliteratum%253Aachs%26jtitle%3DGut%26atitle%3DImpaired%252Bantibacterial%252Bautophagy%252Blinks%252Bgranulomatous%252Bintestinal%252Binflammation%252Bin%252BNiemann%2525E2%252580%252593Pick%252Bdisease%252Btype%252BC1%252Band%252BXIAP%252Bdeficiency%252Bwith%252BNOD2%252Bvariants%252Bin%252BCrohn%252527s%252Bdisease%26aulast%3DSchwerd%26aufirst%3DTobias%26date%3D2017%26date%3D2016%26volume%3D66%26issue%3D6%26spage%3D1060%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duncan E.  Scott</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Bayly</span>, <span class="hlFld-ContribAuthor ">Chris  Abell</span>, <span class="hlFld-ContribAuthor ">John  Skidmore</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules, big targets: drug discovery faces the protein–protein interaction challenge. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2016,</strong> <em>15 </em>
                                    (8)
                                     , 533-550. <a href="https://doi.org/10.1038/nrd.2016.29" title="DOI URL">https://doi.org/10.1038/nrd.2016.29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DSmall%252Bmolecules%25252C%252Bbig%252Btargets%25253A%252Bdrug%252Bdiscovery%252Bfaces%252Bthe%252Bprotein%2525E2%252580%252593protein%252Binteraction%252Bchallenge%26aulast%3DScott%26aufirst%3DDuncan%2BE.%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D8%26spage%3D533%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajay K.  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Neelu  Yadav</span>, <span class="hlFld-ContribAuthor ">Tariq A.  Bhat</span>, <span class="hlFld-ContribAuthor ">Jordan  O’Malley</span>, <span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Dhyan  Chandra</span>. </span><span class="cited-content_cbyCitation_article-title">A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (1)
                                     , 38-47. <a href="https://doi.org/10.1016/j.drudis.2015.07.014" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.07.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.07.014%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DA%252Bpotential%252Brole%252Bof%252BX-linked%252Binhibitor%252Bof%252Bapoptosis%252Bprotein%252Bin%252Bmitochondrial%252Bmembrane%252Bpermeabilization%252Band%252Bits%252Bimplication%252Bin%252Bcancer%252Btherapy%26aulast%3DChaudhary%26aufirst%3DAjay%2BK.%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D38%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher P.  Tinworth</span>, <span class="hlFld-ContribAuthor ">Hannah  Lithgow</span>, <span class="hlFld-ContribAuthor ">Ian  Churcher</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule-mediated protein knockdown as a new approach to drug discovery. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (12)
                                     , 2206-2216. <a href="https://doi.org/10.1039/C6MD00347H" title="DOI URL">https://doi.org/10.1039/C6MD00347H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00347H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00347H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSmall%252Bmolecule-mediated%252Bprotein%252Bknockdown%252Bas%252Ba%252Bnew%252Bapproach%252Bto%252Bdrug%252Bdiscovery%26aulast%3DTinworth%26aufirst%3DChristopher%2BP.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3D2206%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander W  Hird</span>, <span class="hlFld-ContribAuthor ">Brian M  Aquila</span>, <span class="hlFld-ContribAuthor ">Edward J  Hennessy</span>, <span class="hlFld-ContribAuthor ">Melissa M  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitor of apoptosis proteins antagonists: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 755-774. <a href="https://doi.org/10.1517/13543776.2015.1041922" title="DOI URL">https://doi.org/10.1517/13543776.2015.1041922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1041922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1041922%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252Binhibitor%252Bof%252Bapoptosis%252Bproteins%252Bantagonists%25253A%252Ba%252Bpatent%252Breview%26aulast%3DHird%26aufirst%3DAlexander%2BW%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D755%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petra  Obexer</span>, <span class="hlFld-ContribAuthor ">Michael J.  Ausserlechner</span>. </span><span class="cited-content_cbyCitation_article-title">X-Linked Inhibitor of Apoptosis Protein â€“ A Critical Death Resistance Regulator and Therapeutic Target for Personalized Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2014,</strong> <em>4 </em><a href="https://doi.org/10.3389/fonc.2014.00197" title="DOI URL">https://doi.org/10.3389/fonc.2014.00197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2014.00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2014.00197%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DX-Linked%252BInhibitor%252Bof%252BApoptosis%252BProtein%252B%2525C3%2525A2%2525E2%252582%2525AC%2525E2%252580%25259C%252BA%252BCritical%252BDeath%252BResistance%252BRegulator%252Band%252BTherapeutic%252BTarget%252Bfor%252BPersonalized%252BCancer%252BTherapy%26aulast%3DObexer%26aufirst%3DPetra%26date%3D2014%26date%3D2014%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James B  Jaquith</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Inhibitor of Apoptosis Protein BIR3 Binding Domains. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (3)
                                     , 297-312. <a href="https://doi.org/10.4155/ppa.14.16" title="DOI URL">https://doi.org/10.4155/ppa.14.16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.16%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DTargeting%252Bthe%252BInhibitor%252Bof%252BApoptosis%252BProtein%252BBIR3%252BBinding%252BDomains%26aulast%3DJaquith%26aufirst%3DJames%2BB%26date%3D2014%26volume%3D3%26issue%3D3%26spage%3D297%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H.  Ryan</span>, <span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Christopher  Hyland</span>, <span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Jeremy  Just</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 521-571. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00016-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00016-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00016-9%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DRyan%26aufirst%3DJohn%2BH.%26date%3D2014%26spage%3D521%26epage%3D571%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IAP inhibitors. Values for <b>1</b> and <b>2</b> are from refs  <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a> and <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>, respectively. Values for <b>3</b> were generated in-house.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Benzoxazepinone proof-of-concept compound <b>4</b> and plan to address CYP3A4-related liabilities by exploration of benzodiazepinone scaffold <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Unsubstituted and <i>N</i>-Acyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiHMDS, THF, −78 °C; 1-(bromomethyl)naphthalene, 78%; (b) HCl, 1,4-diox, rt, 99%; (c) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 80%; (d) for <b>10a</b>, AcCl; for <b>10b</b>, <i>i</i>-BuCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 37–82%; (e) HCl, 1,4-diox, rt, 70%–quant.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Alkyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 30%; (b) isovaleraldehyde, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 85%; (c) HCl, 1,4-diox, rt, quant; (d) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 81%; (e) HCl, 1,4-diox, rt, quant.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues to Explore the R2 Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCl, 1,4-diox, rt; (b) Boc<i>-N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, quant (2 steps); (c) <i>i</i>-BuCOCl, pyr, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 84%; (d) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (e) HCl, 1,4-diox, rt., 32%–quant (2 steps).</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N-</i>Acyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiHMDS, THF, −78 °C; for <b>16</b>, 1-(chloromethyl)-2-methylnaphthalene, KI, 69%; for <b>19</b>, 6-bromo-1-(chloromethyl)-2-methoxynaphthalene, NaI, 92%; (b) HCl, 1,4-diox, rt; (c) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBPyU, HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 90%–quant (2 steps); (d) for <b>18</b>, <i>i</i>-BuCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 74%; for <b>21a</b>–<b>u</b> (except <b>21r</b>, which was made by a different route, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), R<sup>3</sup>COCl, pyr, CH<sub>2</sub>Cl<sub>2</sub>, 60–95% or R<sup>3</sup>CO<sub>2</sub>H, POCl<sub>3</sub>, pyr, 40%–quant; (e) for <b>21k</b>, H<sub>2</sub> (50 psi), 10% Pd/C, MeOH, rt; (f) HCl, 1,4-diox, rt, 69%–quant, or HCl, Et<sub>2</sub>O, MeOH, rt, 78%–quant.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal structure of <b>21j</b> with XIAP BIR2 domain. (A) The protein is represented as an electrostatic surface. (B) Interactions of the ligand with the peptide-binding groove of the protein. H-bonding interactions between the protein and ligand are represented by black dotted lines labeled with the distance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of <i>trans</i>-Methyl Benzodiazepinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: To prepare <b>26a</b>, the order of steps from <b>24</b> was: h, f, g, i. (a) 1-Fluoro-2-nitrobenzene for <b>23</b> or 3-fluoro-4-nitrobenzonitrile for <b>27</b>, NaHCO<sub>3</sub>, DMF, 85 °C, 78%; (b) LiOH, H<sub>2</sub>O–1,4-diox, rt; (c) H<sub>2</sub>, Pd/C, EtOH, rt; (d) EDCI, DMF, rt, 91% (3 steps) for <b>23</b>, 16% (3 steps) for <b>27</b>; (e) methanesulfonylacetic acid, POCl<sub>3</sub>, pyr, 0 °C, 89–94%; (f) for <b>25</b>, TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; for <b>29</b>, HCl, 1,4-diox, rt; (g) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, <i>i-</i>Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 74–91% (2 steps); (h) R<sup>2</sup> bromide or chloride, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, rt, 38–90%; (i) HCl, 1,4-diox, rt or Et<sub>2</sub>O–MeOH, rt or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Optimized Benzodiazepinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(chloromethyl)-2-methoxynaphthalene or 1-(chloromethyl)-2-methoxynaphthalene, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, rt, 72–80%; (b) AcCl, pyr, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 59–65%; (c) HCl, 1,4-diox, rt; (d) Boc-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 0 °C to rt, 69–70%; (e) HCl, 1,4-diox, rt, 80–87%.</p></p></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/medium/jm-2013-00732v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A,B) Cell-based activity of <b>36</b> and <b>3</b> in combination with DR5 antibody. Proliferation of SW620 cells was evaluated in a 5 day MTS assay upon treatment with DR5 antibody in the presence of varied concentrations of <b>36</b> and <b>3</b>. At 0.5 μg/mL DR5 mAb, <b>36</b> EC<sub>90</sub> = 5.23 ± 1.32 μM, <b>3</b> EC<sub>90</sub> = 6.66 ± 1.51 μM. Values are the mean of two determinations ± SD. (C) Presence of TNFα in supernate from MDA-231 cells 19 h after treatment with the BIR3-selective compound <b>3</b> and BIR2-selective compound <b>36</b>. Values are the mean of two determinations ± SD. (D) The in vivo activity of <b>3</b> and <b>36</b> in combination with the DR5 mAb conatumumab in a LOX melanoma xenograft study measuring caspase 3/7 activity. Mice with LOX xenografts were dosed with conatumumab (single dose 1 mg/kg ip) and test compound (single dose 200 mg/kg po for <b>36</b>; single dose 100 mg/kg po for <b>3</b>). Xenografts were removed after 8 h, homogenized, and analyzed for caspase 3/7 enzyme activity. Mean ± SEM is indicated for each group. Concentration of the test compound in plasma and tumor at 8 h was also determined (<b>36</b>, 5.0 μM plasma, 7.7 μM tumor; <b>3</b>, 3.3 μM plasma, 18.4 μM tumor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400732v/production/images/large/jm-2013-00732v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400732v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lhiedy35LBxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, J. M.</span><span> </span><span class="NLM_article-title">Caspase activation—stepping on the gas or releasing the brakes? Lessons from humans and flies</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2774-2784&author=G.+S.+Salvesenauthor=J.+M.+Abrams&title=Caspase+activation%E2%80%94stepping+on+the+gas+or+releasing+the+brakes%3F+Lessons+from+humans+and+flies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DAbrams%26aufirst%3DJ.%2BM.%26atitle%3DCaspase%2520activation%25E2%2580%2594stepping%2520on%2520the%2520gas%2520or%2520releasing%2520the%2520brakes%253F%2520Lessons%2520from%2520humans%2520and%2520flies%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2774%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creutzig, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karawajew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, W.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuchter, C.</span><span> </span><span class="NLM_article-title">High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3737</span><span class="NLM_x">–</span> <span class="NLM_lpage">3744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1158%2F1078-0432.CCR-03-0642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3737-3744&author=I.+Tammauthor=S.+Richterauthor=D.+Oltersdorfauthor=U.+Creutzigauthor=J.+Harbottauthor=F.+Scholzauthor=L.+Karawajewauthor=W.-D.+Ludwigauthor=C.+Wuchter&title=High+Expression+Levels+of+X-Linked+Inhibitor+of+Apoptosis+Protein+and+Survivin+Correlate+with+Poor+Overall+Survival+in+Childhood+de+Novo+Acute+Myeloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia</span></div><div class="casAuthors">Tamm, Ingo; Richter, Stephan; Oltersdorf, Doreen; Creutzig, Ursula; Harbott, Jochen; Scholz, Frank; Karawajew, Leonid; Ludwig, Wolf-Dieter; Wuchter, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3737-3744</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Apoptosis-related proteins are important mols. for predicting chemotherapy response and prognosis in adult acute myeloid leukemia (AML).  However, data on the expression and prognostic impact of these mols. in childhood AML are rare.  Using flow cytometry and Western blot anal., the authors, therefore, investigated 45 leukemic cell samples from children with de novo AML enrolled and treated within the German AML-BFM93 study for the expression of apoptosis-regulating proteins [CD95, Bcl-2, Bax, Bcl-xL, procaspase-3, X-linked inhibitor of apoptosis protein (XIAP), cellular inhibitor of apoptosis protein-1 (cIAP-1), survivin].  XIAP but no other apoptosis regulators showed maturation-dependent expression differences as detd. by French-American-British (FAB) morphol. with the highest expression levels obsd. within the immature M0/1 subtypes.  XIAP and Bcl-xL expression was lower in patients with favorable rather than intermediate/poor cytogenetics.  After a mean follow-up of 34 mo, a shorter overall survival was assocd. with high expression levels of XIAP [30 vs. 41 mo; ] and survivin [27 vs. 41 mo; ].  Thus, the authors conclude that apoptosis-related mols. are assocd. with maturation stage, cytogenetic risk groups, and therapy outcome in childhood de novo AML.  The obsd. assocn. of XIAP with immature FAB types, intermediate/poor cytogenetics, and poor overall survival should be confirmed within prospective pediatric AML trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1ZJd4xSI97Vg90H21EOLACvtfcHk0lhiedy35LBxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKntr0%253D&md5=334d7a3d4ba005c1ff4fc804f88d59f0</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0642%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DRichter%26aufirst%3DS.%26aulast%3DOltersdorf%26aufirst%3DD.%26aulast%3DCreutzig%26aufirst%3DU.%26aulast%3DHarbott%26aufirst%3DJ.%26aulast%3DScholz%26aufirst%3DF.%26aulast%3DKarawajew%26aufirst%3DL.%26aulast%3DLudwig%26aufirst%3DW.-D.%26aulast%3DWuchter%26aufirst%3DC.%26atitle%3DHigh%2520Expression%2520Levels%2520of%2520X-Linked%2520Inhibitor%2520of%2520Apoptosis%2520Protein%2520and%2520Survivin%2520Correlate%2520with%2520Poor%2520Overall%2520Survival%2520in%2520Childhood%2520de%2520Novo%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D3737%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tamm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karawajew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haferlach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuchter, C.</span><span> </span><span class="NLM_article-title">XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis</span> <span class="citation_source-journal">Hematol. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2Fsj.thj.6200549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=15570290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVagtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=489-495&author=I.+Tammauthor=S.+Richterauthor=F.+Scholzauthor=K.+Schmelzauthor=D.+Oltersdorfauthor=L.+Karawajewauthor=D.+Schochauthor=T.+Haferlachauthor=W.+D.+Ludwigauthor=C.+Wuchter&title=XIAP+expression+correlates+with+monocytic+differentiation+in+adult+de+novo+AML%3A+impact+on+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis</span></div><div class="casAuthors">Tamm, Ingo; Richter, Stephan; Scholz, Frank; Schmelz, Karin; Oltersdorf, Doreen; Karawajew, Leonid; Schoch, Claudia; Haferlach, Torsten; Ludwig, Wolf-Dieter; Wuchter, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Hematology Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">489-495</span>CODEN:
                <span class="NLM_cas:coden">HJEOBZ</span>;
        ISSN:<span class="NLM_cas:issn">1466-4860</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antiapoptotic proteins like the inhibitor of apoptosis proteins (IAPs) are mol. markers potentially useful for the characterization of acute myeloid leukemia (AML).  The authors screened 92 adults with de novo AML for the protein expression of various IAPs, Bcl-2 family members and the proform of Caspase-3 using quant. immunoblot and flow cytometry.  XIAP expression correlated with myelomonocytic French-American-British (FAB) subtypes M4/M5 and expression of monocytic markers (CD14, CD36, CD4, HLA-DR) in AML blasts.  In addn., XIAP was overexpressed in normal monocytes but undetectable in granulocytes.  In AML, XIAP expression was significantly lower in patients with favorable than intermediate or poor cytogenetics.  In total, 62 of the examd. patients were treated according to the German AML Cooperative Group (AMLCG) 92 protocol.  These patients were analyzed for prognostic significance of apoptosis-related proteins.  Patients expressing low levels of XIAP enjoyed better overall survival than patients expressing high amts. of XIAP (mean, 9 vs. 19 mo).  Other IAPs, most importantly Survivin, were of no prognostic value.  The authors conclude that XIAP but not other IAP family members is assocd. with monocytic differentiation in normal and malignant myelopoiesis, and may be of prognostic significance for overall survival in adult de novo AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppTLew01DAx7Vg90H21EOLACvtfcHk0lhiedy35LBxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVagtrzP&md5=5b0941f3eb48d464c9df45cb930817b8</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fsj.thj.6200549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.thj.6200549%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DRichter%26aufirst%3DS.%26aulast%3DScholz%26aufirst%3DF.%26aulast%3DSchmelz%26aufirst%3DK.%26aulast%3DOltersdorf%26aufirst%3DD.%26aulast%3DKarawajew%26aufirst%3DL.%26aulast%3DSchoch%26aufirst%3DD.%26aulast%3DHaferlach%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DW.%2BD.%26aulast%3DWuchter%26aufirst%3DC.%26atitle%3DXIAP%2520expression%2520correlates%2520with%2520monocytic%2520differentiation%2520in%2520adult%2520de%2520novo%2520AML%253A%2520impact%2520on%2520prognosis%26jtitle%3DHematol.%2520J.%26date%3D2004%26volume%3D5%26spage%3D489%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kluger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvero, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sznol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimm, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, G.</span><span> </span><span class="NLM_article-title">The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1186%2F1479-5876-5-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FptVKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=6&author=H.+M.+Klugerauthor=M.+M.+McCarthyauthor=A.+B.+Alveroauthor=M.+Sznolauthor=S.+Ariyanauthor=R.+L.+Campauthor=D.+L.+Rimmauthor=G.+Mor&title=The+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29+is+up-regulated+in+metastatic+melanoma%2C+and+XIAP+cleavage+by+phenoxodiol+is+associated+with+carboplatin+sensitization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization</span></div><div class="casAuthors">Kluger Harriet M; McCarthy Mary M; Alvero Ayesha B; Sznol Mario; Ariyan Stephan; Camp Robert L; Rimm David L; Mor Gil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">XIAP up-regulation is associated with chemotherapy resistance.  Phenoxodiol causes XIAP degradation and chemotherapy sensitization in ovarian cancer.  Here we assessed XIAP expression in melanomas, using tissue microarrays containing 436 melanomas and 336 nevi by a novel method of automated, quantitative analysis (AQUA).  We used S100 to define pixels as melanoma (tumor mask) within the array spot, and measured XIAP expression using Cy5-conjugated antibodies within the mask.  XIAP expression was significantly higher in melanomas than nevi (P < 0.0001), and higher in metastatic than primary lesions (P < 0.0001).  We then assessed a panel of melanoma cell lines for XIAP expression, and found high expression in all cell lines.  Three of the cell lines were assessed for Phenoxodiol and Carboplatin sensitivity; all were resistant to Carboplatin and showed variable sensitivity to Phenoxodiol.  Pre-treating Phenoxodiol sensitive cells with Phenoxodiol prior to Carboplatin resulted in XIAP degradation, associated with Carboplatin sensitization and apoptosis, whereas exposing Phenoxodiol resistant cells to Phenoxodiol resulted in less XIAP degradation and minimal Carboplatin sensitization.  We conclude that XIAP levels in clinical specimens are significantly higher in melanomas than their benign counterparts, and higher in metastatic than in primary specimens, suggesting an association with malignant progression and disease aggression.  Melanoma resistance to Carboplatin is possibly due to XIAP over-expression.  Phenoxodiol can sensitize melanoma cells to Carboplatin in vitro with corresponding XIAP degradation, although the precise target and mechanism of action of Phenoxodiol are subject to further assessment.  Targeting XIAP warrants additional investigation as a therapeutic approach for metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ00ycMsdB7xlw2ofyr07jXfW6udTcc2eYnkHTg8cTqdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FptVKhuw%253D%253D&md5=554ff553eaef6ecb1af8fae4ee04e365</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-5-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-5-6%26sid%3Dliteratum%253Aachs%26aulast%3DKluger%26aufirst%3DH.%2BM.%26aulast%3DMcCarthy%26aufirst%3DM.%2BM.%26aulast%3DAlvero%26aufirst%3DA.%2BB.%26aulast%3DSznol%26aufirst%3DM.%26aulast%3DAriyan%26aufirst%3DS.%26aulast%3DCamp%26aufirst%3DR.%2BL.%26aulast%3DRimm%26aufirst%3DD.%2BL.%26aulast%3DMor%26aufirst%3DG.%26atitle%3DThe%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%2520is%2520up-regulated%2520in%2520metastatic%2520melanoma%252C%2520and%2520XIAP%2520cleavage%2520by%2520phenoxodiol%2520is%2520associated%2520with%2520carboplatin%2520sensitization%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2007%26volume%3D5%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mizutani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukimura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawauchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, T.</span><span> </span><span class="NLM_article-title">Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=17332931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1WhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=919-925&author=Y.+Mizutaniauthor=H.+Nakanishiauthor=Y.+N.+Liauthor=H.+Matsubaraauthor=K.+Yamamotoauthor=N.+Satoauthor=T.+Shiraishiauthor=T.+Nakamuraauthor=K.+Mikamiauthor=K.+Okiharaauthor=N.+Takahaauthor=O.+Ukimuraauthor=A.+Kawauchiauthor=N.+Nonomuraauthor=B.+Bonavidaauthor=T.+Miki&title=Overexpression+of+XIAP+expression+in+renal+cell+carcinoma+predicts+a+worse+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis</span></div><div class="casAuthors">Mizutani, Yoichi; Nakanishi, Hiroyuki; Li, Yong Nan; Matsubara, Hiroki; Yamamoto, Kosuke; Sato, Nodoka; Shiraishi, Takumi; Nakamura, Terukazu; Mikami, Kazuya; Okihara, Koji; Takaha, Natsuki; Ukimura, Osamu; Kawauchi, Akihiro; Nonomura, Norio; Bonavida, Benjamin; Miki, Tsuneharu</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">919-925</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">X-linked inhibitor of apoptosis protein (XIAP) is the most potent caspase-inhibitory IAP family member and a neg. regulator of various apoptotic stimuli.  Thus, XIAP overexpression in cancer cells may select for tumor cell survival following various cytotoxic therapeutic modalities.  The anatomical staging system in renal cell carcinoma (RCC) currently provides good prognostic information, albeit insufficient.  We hypothesize that overexpression of XIAP in RCC may serve as a mol. prognostic marker in RCC and improve the staging of RCC.  This study examd. the protein level of XIAP in lysates from surgical specimens of 109 patients with RCC and 109 normal kidney specimens from the same patients.  The level of XIAP expression was quantified by Western blot anal. using non-fixed fresh frozen tissues of RCCs and normal kidneys.  Results indicated that the mean level of XIAP expression was higher in RCC compared to autologous normal kidney, and the XIAP expression level in 38/109 (35%) of RCC was more than 2-fold greater than that in normal kidney tissue.  In Stage I/II RCC, the mean XIAP expression level was almost identical to that detected in normal kidney, whereas XIAP expression in Stage III/IV was 2.5-fold higher than that in Stage I/II RCC.  Levels of XIAP expression also correlated with the grade of RCC.  Patients with RCC with low XIAP expression had a longer postoperative disease-specific survival as compared to those with high expression in the 5-yr follow-up.  The suggested role of XIAP in the regulation of resistance in apoptosis was examd. in vitro following treatment of RCC cell lines with XIAP antisense oligonucleotide and the cells were sensitized to both Fas-mediated and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis.  The present study demonstrates at the protein level that XIAP is overexpressed in RCC, and that high XIAP expression in RCC predicted a worse prognosis.  In addn., XIAP antisense oligonucleotide sensitized RCC to Fas/TRAIL-induced apoptosis.  These results suggest that XIAP expression in RCC may be used as a prognostic parameter, and that downregulation or inhibition of XIAP expression in RCC may reverse immune resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpmszQw07lrVg90H21EOLACvtfcHk0lhcxIHAsR0jNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1WhtLs%253D&md5=ec34df06bcd09c4d2e95e6116dd967d2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DY.%26aulast%3DNakanishi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%2BN.%26aulast%3DMatsubara%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMikami%26aufirst%3DK.%26aulast%3DOkihara%26aufirst%3DK.%26aulast%3DTakaha%26aufirst%3DN.%26aulast%3DUkimura%26aufirst%3DO.%26aulast%3DKawauchi%26aufirst%3DA.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DMiki%26aufirst%3DT.%26atitle%3DOverexpression%2520of%2520XIAP%2520expression%2520in%2520renal%2520cell%2520carcinoma%2520predicts%2520a%2520worse%2520prognosis%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2007%26volume%3D30%26spage%3D919%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Miller, L. K.</span><span> </span><span class="NLM_article-title">An exegesis of IAPs: salvation and surprises from BIR motifs</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2FS0962-8924%2899%2901609-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10407412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADyaK1MXltFyjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=323-328&author=L.+K.+Miller&title=An+exegesis+of+IAPs%3A+salvation+and+surprises+from+BIR+motifs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An exegesis of IAPs: salvation and surprises from BIR motifs</span></div><div class="casAuthors">Miller, Lois K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">323-328</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with ∼43 refs.  The BIR (baculovirus IAP repeat) motif is a conserved sequence of approx. 70 amino acids that was identified originally in the "inhibitor of apoptosis" (IAP) family of proteins.  BIR-contg. proteins (BIRPs) are found in viruses, yeast and metazoans.  Recent genetic anal. of a nematode BIRP demonstrated an essential role in cytokinesis instead of apoptosis.  It is likely that BIRs originated in eukaryotes to serve a role in cytokinesis and/or mitotic spindle function during cell division and that, with gene duplication, the more recent adaptation of some BIRPs to the regulation of apoptosis was possible.  IAPs interact with a variety of proteins, including members of the caspase protease family.  This article discusses current research on the structure and function of the BIR motifs and how it could provide insight into the function of BIRPs in cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkv-DdasIG5LVg90H21EOLACvtfcHk0lhcxIHAsR0jNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFyjtbs%253D&md5=91ae24d1acce1bc163d2c5514391f2e1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2899%2901609-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252899%252901609-8%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BK.%26atitle%3DAn%2520exegesis%2520of%2520IAPs%253A%2520salvation%2520and%2520surprises%2520from%2520BIR%2520motifs%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1999%26volume%3D9%26spage%3D323%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Cytochrome C-Mediated Apoptosis</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1146%2Fannurev.biochem.73.011303.073706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=15189137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=87-106&author=X.+Jiangauthor=X.+Wang&title=Cytochrome+C-Mediated+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome C-mediated apoptosis</span></div><div class="casAuthors">Jiang, Xuejun; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-106</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Apoptosis, or programmed cell death, is involved in development, elimination of damaged cells, and maintenance of cell homeostasis.  Deregulation of apoptosis may cause diseases, such as cancers, immune diseases, and neurodegenerative disorders.  Apoptosis is executed by a subfamily of cysteine proteases known as caspases.  In mammalian cells, a major caspase activation pathway is the cytochrome c-initiated pathway.  In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochem. reactions that result in caspase activation and subsequent cell death.  This review focused on the recent progress in understanding the biochem. mechanisms and regulation of the pathway, the roles of the pathway in physiol. and disease, and their potential therapeutic values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaXd15zPESYLVg90H21EOLACvtfcHk0lhwgog_-1w2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D&md5=a8e668a41a4b4d0994a128019967f28d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073706%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DCytochrome%2520C-Mediated%2520Apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D87%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ashkenazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span> </span><span class="NLM_article-title">Death Receptors: Signaling and Modulation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1126%2Fscience.281.5381.1305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=9721089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1305-1308&author=A.+Ashkenaziauthor=V.+M.+Dixit&title=Death+Receptors%3A+Signaling+and+Modulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Death receptors: Signaling and modulation</span></div><div class="casAuthors">Ashkenazi, Avi; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5381</span>),
    <span class="NLM_cas:pages">1305-1308</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 61 refs.  Apoptosis is a cell suicide mechanism that enables metazoans to control cell no. in tissues and to eliminate individual cells that threaten the animal's survival.  Certain cells have unique sensors, termed death receptors, on their surface.  Death receptors detect the presence of extracellular death signals and, in response, they rapidly ignite the cell's intrinsic apoptosis machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5qJid4f9QLVg90H21EOLACvtfcHk0lhwgog_-1w2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D&md5=9bd9f0e6b358e7cfa3b509dec7fbbe8f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5381.1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5381.1305%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DDeath%2520Receptors%253A%2520Signaling%2520and%2520Modulation%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1305%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fuentes-Prior, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span> </span><span class="NLM_article-title">The protein structures that shape caspase activity, specificity, activation and inhibition</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1042%2FBJ20041142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=15450003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSqs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2004&pages=201-232&author=P.+Fuentes-Priorauthor=G.+S.+Salvesen&title=The+protein+structures+that+shape+caspase+activity%2C+specificity%2C+activation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The protein structures that shape caspase activity, specificity, activation and inhibition</span></div><div class="casAuthors">Fuentes-Prior, Pablo; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-232</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The death morphol. commonly known as apoptosis results from a post-translational pathway driven largely by specific limited proteolysis.  In the last decade the structural basis for apoptosis regulation has moved from nothing to 'quite good', and we now know the fundamental structures of examples from the initiator phase, the pre-mitochondrial regulator phase, the executioner phase, inhibitors and their antagonists, and even the structures of some substrates.  The field is as well advanced as the best known of proteolytic pathways, the coagulation cascade.  Fundamentally new mechanisms in protease regulation have been disclosed.  Structural evidence suggests that caspases have an unusual catalytic mechanism, and that they are activated by apparently unrelated events, depending on which position in the apoptotic pathway they occupy.  Some naturally occurring caspase inhibitors have adopted classic inhibition strategies, but other have revealed completely novel mechanisms.  All of the structural and mechanistic information can, and is, being applied to drive therapeutic strategies to combat overactivation of apoptosis in degenerative disease, and underactivation in neoplasia.  We present a comprehensive review of the caspases, their regulators and inhibitors from a structural and mechanistic point of view, and with an aim to consolidate the many threads that define the rapid growth of this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowJ7v8n99EJrVg90H21EOLACvtfcHk0lhwgog_-1w2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSqs7rP&md5=b3c9b22933c76e89ee5fa993e9ec2247</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBJ20041142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20041142%26sid%3Dliteratum%253Aachs%26aulast%3DFuentes-Prior%26aufirst%3DP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DThe%2520protein%2520structures%2520that%2520shape%2520caspase%2520activity%252C%2520specificity%252C%2520activation%2520and%2520inhibition%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D384%26spage%3D201%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Eckelman, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, F. L.</span><span> </span><span class="NLM_article-title">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2Fsj.embor.7400795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=17016456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=988-994&author=B.+P.+Eckelmanauthor=G.+S.+Salvesenauthor=F.+L.+Scott&title=Human+inhibitor+of+apoptosis+proteins%3A+why+XIAP+is+the+black+sheep+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.; Scott, Fiona L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-994</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several of the inhibitor of apoptosis protein (IAP) family members regulate apoptosis in response to various cellular assaults.  Some members are also involved in cell signaling, mitosis and targeting proteins to the ubiquitin-proteasome degrdn. machinery.  The most intensively studied family member, X-linked IAP (XIAP), is a potent inhibitor of caspase activity; hence, it is generally assumed that direct caspase inhibition is an important conserved function of most members of the family.  Biochem. and structural studies have precisely mapped the elements of XIAP required for caspase inhibition.  Intriguingly, these elements are not conserved among IAPs.  Here, we review current knowledge of the caspase-inhibitory potential of the human IAPs and show that XIAP is probably the only bona fide caspase inhibitor, suggesting that the other family members never gained the ability to directly inhibit caspase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2WCkDI8Vs7Vg90H21EOLACvtfcHk0lhwgog_-1w2sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K&md5=7db7a68e171e0303dd25ba6e2a97be34</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400795%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DScott%26aufirst%3DF.%2BL.%26atitle%3DHuman%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520why%2520XIAP%2520is%2520the%2520black%2520sheep%2520of%2520the%2520family%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D988%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Smac, a Mitochondrial Protein that Promotes Cytochrome c-Dependent Caspase Activation by Eliminating IAP Inhibition</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2FS0092-8674%2800%2900008-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10929711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=33-42&author=C.+Duauthor=M.+Fangauthor=Y.+Liauthor=L.+Liauthor=X.+Wang&title=Smac%2C+a+Mitochondrial+Protein+that+Promotes+Cytochrome+c-Dependent+Caspase+Activation+by+Eliminating+IAP+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span></div><div class="casAuthors">Du, Chunying; Fang, Min; Li, Yucheng; Li, Lily; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway.  Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity.  Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis.  Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity.  Overexpression of Smac increases cells' sensitivity to apoptotic stimuli.  Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUyaGmAsnprVg90H21EOLACvtfcHk0lg9YafsOdCGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D&md5=8321d44bed77ff7c2da398e1b02f9e20</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900008-8%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSmac%252C%2520a%2520Mitochondrial%2520Protein%2520that%2520Promotes%2520Cytochrome%2520c-Dependent%2520Caspase%2520Activation%2520by%2520Eliminating%2520IAP%2520Inhibition%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D33%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verhagen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekert, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pakusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span> </span><span class="NLM_article-title">Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2FS0092-8674%2800%2900009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10929712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=43-53&author=A.+M.+Verhagenauthor=P.+G.+Ekertauthor=M.+Pakuschauthor=J.+Silkeauthor=L.+M.+Connollyauthor=G.+E.+Reidauthor=R.+L.+Moritzauthor=R.+J.+Simpsonauthor=D.+L.+Vaux&title=Identification+of+DIABLO%2C+a+Mammalian+Protein+that+Promotes+Apoptosis+by+Binding+to+and+Antagonizing+IAP+Proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span></div><div class="casAuthors">Verhagen, Anne M.; Ekert, Paul G.; Pakusch, Miha; Silke, John; Connolly, Lisa M.; Reid, Gavin E.; Moritz, Robert L.; Simpson, Richard J.; Vaux, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunopptn. and 2D immobilized pH gradient/SDS-PAGE, followed by electrospray ionization tandem mass spectrometry.  DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP.  The N-terminally processed, IAP-interacting form of DIABLO is concd. in membrane fractions in healthy cells but released into the MIHA-contg. cytosolic fractions upon UV irradn.  As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradn., DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-TYWHjxeE7Vg90H21EOLACvtfcHk0lg9YafsOdCGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D&md5=475519bd43e9d625b06b0293895d9693</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900009-X%26sid%3Dliteratum%253Aachs%26aulast%3DVerhagen%26aufirst%3DA.%2BM.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DPakusch%26aufirst%3DM.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DL.%2BM.%26aulast%3DReid%26aufirst%3DG.%2BE.%26aulast%3DMoritz%26aufirst%3DR.%2BL.%26aulast%3DSimpson%26aufirst%3DR.%2BJ.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520DIABLO%252C%2520a%2520Mammalian%2520Protein%2520that%2520Promotes%2520Apoptosis%2520by%2520Binding%2520to%2520and%2520Antagonizing%2520IAP%2520Proteins%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suber, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of IAP recognition by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.-W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0lg9YafsOdCGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+Smac%2FDIABLO+to+the+XIAP+BIR3+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third β-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0lg9YafsOdCGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520Smac%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">In addition to the molecules specifically mentioned in this paper, other monovalent XIAP inhibitors have been reported, as well as bivalent inhibitors such as AEG40826/HGS1029, which has also entered the clinic. For further discussion, see ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+Potent+and+Orally+Active+Antagonist+%28SM-406%2FAT-406%29+of+Multiple+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+in+Clinical+Development+for+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0lgoNMsRAmKc7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Active%2520Antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520in%2520Clinical%2520Development%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4101</span><span class="NLM_x">–</span> <span class="NLM_lpage">4113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&author=J.+A.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.-P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+A.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+Potent+Small-Molecule+Antagonist+of+Inhibitor+of+Apoptosis+%28IAP%29+Proteins+and+Clinical+Candidate+for+the+Treatment+of+Cancer+%28GDC-0152%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 ± 3 mL/min/kg, and the vol. of distribution was 0.6 ± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0lgoNMsRAmKc7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.-P.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Small-Molecule%2520Antagonist%2520of%2520Inhibitor%2520of%2520Apoptosis%2520%2528IAP%2529%2520Proteins%2520and%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4101%26epage%3D4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carol, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billups, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program</span> <span class="citation_source-journal">Pediatr. Blood Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1002%2Fpbc.23167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=636-639&author=P.+J.+Houghtonauthor=M.+H.+Kangauthor=C.+P.+Reynoldsauthor=C.+L.+Mortonauthor=E.+A.+Kolbauthor=R.+Gorlickauthor=S.+T.+Keirauthor=H.+Carolauthor=R.+Lockauthor=J.+M.+Marisauthor=C.+A.+Billupsauthor=M.+A.+Smith&title=Initial+Testing+%28Stage+1%29+of+LCL161%2C+a+SMAC+Mimetic%2C+by+the+Pediatric+Preclinical+Testing+Program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program</span></div><div class="casAuthors">Houghton Peter J; Kang Min H; Reynolds C Patrick; Morton Christopher L; Kolb E Anders; Gorlick Richard; Keir Stephen T; Carol Hernan; Lock Richard; Maris John M; Billups Catherine A; Smith Malcolm A</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric blood & cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 μM) and the PPTP in vivo panels (30 or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice in a week.  LCL161 showed a median relative IC(50) value of >10 μM, being more potent against several leukemia and lymphoma lines.  In vivo LCL161 induced significant differences in EFS distribution in approximately one-third of solid tumor xenografts (osteosarcoma and glioblastoma), but not in ALL xenografts.  No objective tumor responses were observed.  In vivo LCL161 demonstrated limited single agent activity against the pediatric preclinical models studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSUatUzOMj4MULxIEhxUjPfW6udTcc2ebGgc9BtNUP5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D&md5=39302864067c6f9d1bfc9fca041d6c3c</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1002%2Fpbc.23167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.23167%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DKang%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DMorton%26aufirst%3DC.%2BL.%26aulast%3DKolb%26aufirst%3DE.%2BA.%26aulast%3DGorlick%26aufirst%3DR.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DCarol%26aufirst%3DH.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DBillups%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DInitial%2520Testing%2520%2528Stage%25201%2529%2520of%2520LCL161%252C%2520a%2520SMAC%2520Mimetic%252C%2520by%2520the%2520Pediatric%2520Preclinical%2520Testing%2520Program%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2012%26volume%3D58%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, K.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.-L.</span><span> </span><span class="NLM_article-title">Inhibition of Bcl-2 improves effect of LCL 161, a SMAC, mimetic in hepatocellular carcinoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=268-277&author=K.-F.+Chenauthor=J.-P.+Linauthor=C.-W.+Shiauauthor=W.-T.+Taiauthor=C.-Y.+Liuauthor=H.-C.+Yuauthor=P.-J.+Chenauthor=A.-L.+Cheng&title=Inhibition+of+Bcl-2+improves+effect+of+LCL+161%2C+a+SMAC%2C+mimetic+in+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.-F.%26aulast%3DLin%26aufirst%3DJ.-P.%26aulast%3DShiau%26aufirst%3DC.-W.%26aulast%3DTai%26aufirst%3DW.-T.%26aulast%3DLiu%26aufirst%3DC.-Y.%26aulast%3DYu%26aufirst%3DH.-C.%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DCheng%26aufirst%3DA.-L.%26atitle%3DInhibition%2520of%2520Bcl-2%2520improves%2520effect%2520of%2520LCL%2520161%252C%2520a%2520SMAC%252C%2520mimetic%2520in%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D268%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-123&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-C.</span><span> </span><span class="NLM_article-title">Smac Mimetics and TNFα: A Dangerous Liaison?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=655-658&author=H.+Wuauthor=J.+Tschoppauthor=S.-C.+Lin&title=Smac+Mimetics+and+TNF%CE%B1%3A+A+Dangerous+Liaison%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DTschopp%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DS.-C.%26atitle%3DSmac%2520Mimetics%2520and%2520TNF%25CE%25B1%253A%2520A%2520Dangerous%2520Liaison%253F%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D655%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Gonzalez-Lopez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriete, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">–</span> <span class="NLM_lpage">4336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1016%2Fj.bmcl.2011.05.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=21680182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4332-4336&author=M.+Gonzalez-Lopezauthor=K.+Welshauthor=D.+Finlayauthor=R.+J.+Ardeckyauthor=S.+R.+Ganjiauthor=Y.+Suauthor=H.+Yuanauthor=P.+Terieteauthor=P.+D.+Maceauthor=S.+J.+Riedlauthor=K.+Vuoriauthor=J.+C.+Reedauthor=N.+D.+P.+Cosford&title=Design%2C+synthesis+and+evaluation+of+monovalent+Smac+mimetics+that+bind+to+the+BIR2+domain+of+the+anti-apoptotic+protein+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP</span></div><div class="casAuthors">Gonzalez-Lopez, Marcos; Welsh, Kate; Finlay, Darren; Ardecky, Robert J.; Ganji, Santhi Reddy; Su, Ying; Yuan, Hongbin; Teriete, Peter; Mace, Peter D.; Riedl, Stefan J.; Vuori, Kristiina; Reed, John C.; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4332-4336</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein is reported the systematic rational design and synthesis of new monovalent Smac mimetics that bind preferentially to the BIR2 domain of the anti-apoptotic protein XIAP.  Characterization of compds. in vitro (including I; ML101) led to the detn. of key structural requirements for BIR2 binding affinity.  Compds. II and III sensitized TRAIL-resistant breast cancer cells to apoptotic cell death, highlighting the value of these probe compds. as tools to investigate the biol. of XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbRdeoMcYXrVg90H21EOLACvtfcHk0lge2zNEpQN7ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWrtrg%253D&md5=c5b3ba8d8e84accb61d9a157972791da</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.049%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%26aufirst%3DM.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DFinlay%26aufirst%3DD.%26aulast%3DArdecky%26aufirst%3DR.%2BJ.%26aulast%3DGanji%26aufirst%3DS.%2BR.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DTeriete%26aufirst%3DP.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520monovalent%2520Smac%2520mimetics%2520that%2520bind%2520to%2520the%2520BIR2%2520domain%2520of%2520the%2520anti-apoptotic%2520protein%2520XIAP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4332%26epage%3D4336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Donnell, A. F.; Michoud, C.; Rupert, K. C.; Han, X.; Aguilar, D.; Frank, K. B.; Fretland, A. J.; Gao, L.; Goggin, B.; Hogg, J. H.; Hong, K.; Janson, C. A.; Kester, R. F.; Kong, N.; Le, K.; Li, S.; Liang, W.; Lombardo, L. J.; Lou, Y.; Lukacs, C.; Mischke, S.; Moliterni, J. A.; Polonskaia, A.; Schutt, A. D.; Solis, D. S.; Specian, A.; Taylor, R. T.; Weisel, M.; Remiszewski, S. W.</span><span> </span><span class="NLM_article-title">Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1021/jm400731m</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400731m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+F.+Donnell&author=C.+Michoud&author=K.+C.+Rupert&author=X.+Han&author=D.+Aguilar&author=K.+B.+Frank&author=A.+J.+Fretland&author=L.+Gao&author=B.+Goggin&author=J.+H.+Hogg&author=K.+Hong&author=C.+A.+Janson&author=R.+F.+Kester&author=N.+Kong&author=K.+Le&author=S.+Li&author=W.+Liang&author=L.+J.+Lombardo&author=Y.+Lou&author=C.+Lukacs&author=S.+Mischke&author=J.+A.+Moliterni&author=A.+Polonskaia&author=A.+D.+Schutt&author=D.+S.+Solis&author=A.+Specian&author=R.+T.+Taylor&author=M.+Weisel&author=S.+W.+Remiszewski&title=Benzazepinones+and+Benzoxazepinones+as+Antagonists+of+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+Selective+for+the+Second+Baculovirus+IAP+Repeat+%28BIR2%29+Domain&doi=10.1021%2Fjm400731m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400731m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400731m%26sid%3Dliteratum%253Aachs%26aulast%3DDonnell%26aufirst%3DA.%2BF.%26atitle%3DBenzazepinones%2520and%2520Benzoxazepinones%2520as%2520Antagonists%2520of%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520Selective%2520for%2520the%2520Second%2520Baculovirus%2520IAP%2520Repeat%2520%2528BIR2%2529%2520Domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400731m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Schutt, A.; Goggin, B. S.; Hong, K.; Polonskaia, A.; To, T.; Tardell, C.; Dvorozniak, M.; Tannu, S.; Aguilar, D.; Solis, D.; Gao, L.; Lukacs, C.; Jansen, G.; Hilton, H.; Fretland, A.; Liang, Z.; Lee, K.; Kester, R.; Donnell, A.; Mischke, S.; Han, X.; Chen, S.; Le, N.; Lou, Y.; Remiszewski, S.; Packman, K.; Lee, E. C.</span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schutt%2C+A.%3B+Goggin%2C+B.+S.%3B+Hong%2C+K.%3B+Polonskaia%2C+A.%3B+To%2C+T.%3B+Tardell%2C+C.%3B+Dvorozniak%2C+M.%3B+Tannu%2C+S.%3B+Aguilar%2C+D.%3B+Solis%2C+D.%3B+Gao%2C+L.%3B+Lukacs%2C+C.%3B+Jansen%2C+G.%3B+Hilton%2C+H.%3B+Fretland%2C+A.%3B+Liang%2C+Z.%3B+Lee%2C+K.%3B+Kester%2C+R.%3B+Donnell%2C+A.%3B+Mischke%2C+S.%3B+Han%2C+X.%3B+Chen%2C+S.%3B+Le%2C+N.%3B+Lou%2C+Y.%3B+Remiszewski%2C+S.%3B+Packman%2C+K.%3B+Lee%2C+E.+C.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSchutt%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lauffer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullican, M. D.</span><span> </span><span class="NLM_article-title">A Practical Synthesis of (<i>S</i>) 3-<i>tert</i>-Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic Acid Methyl Ester as a Conformationally Restricted Dipeptido-Mimetic for Caspase-1 (ICE) Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1225-1227&author=D.+J.+Laufferauthor=M.+D.+Mullican&title=A+Practical+Synthesis+of+%28S%29+3-tert-Butoxycarbonylamino-2-oxo-2%2C3%2C4%2C5-tetrahydro-1%2C5-benzodiazepine-1-acetic+Acid+Methyl+Ester+as+a+Conformationally+Restricted+Dipeptido-Mimetic+for+Caspase-1+%28ICE%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauffer%26aufirst%3DD.%2BJ.%26aulast%3DMullican%26aufirst%3DM.%2BD.%26atitle%3DA%2520Practical%2520Synthesis%2520of%2520%2528S%2529%25203-tert-Butoxycarbonylamino-2-oxo-2%252C3%252C4%252C5-tetrahydro-1%252C5-benzodiazepine-1-acetic%2520Acid%2520Methyl%2520Ester%2520as%2520a%2520Conformationally%2520Restricted%2520Dipeptido-Mimetic%2520for%2520Caspase-1%2520%2528ICE%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1225%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lukacs, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belunis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowhter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danho, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remiszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">The Crystal Structure of XIAP-BIR2: Understanding selectivity of the BIR domains</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D.: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1717-1725&author=C.+M.+Lukacsauthor=C.+Belunisauthor=R.+Crowhterauthor=W.+Danhoauthor=L.+Gaoauthor=B.+Gogginauthor=C.+A.+Jansonauthor=S.+Liauthor=S.+Remiszewskiauthor=A.+Schuttauthor=M.+K.+Thakurauthor=S.+K.+Singhauthor=S.+Swaminathanauthor=R.+Pandeyauthor=R.+Tyagiauthor=R.+Gosuauthor=A.+V.+Kamathauthor=A.+Kuglstatter&title=The+Crystal+Structure+of+XIAP-BIR2%3A+Understanding+selectivity+of+the+BIR+domains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukacs%26aufirst%3DC.%2BM.%26aulast%3DBelunis%26aufirst%3DC.%26aulast%3DCrowhter%26aufirst%3DR.%26aulast%3DDanho%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRemiszewski%26aufirst%3DS.%26aulast%3DSchutt%26aufirst%3DA.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DR.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520Crystal%2520Structure%2520of%2520XIAP-BIR2%253A%2520Understanding%2520selectivity%2520of%2520the%2520BIR%2520domains%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D.%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1717%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Dobler, M. R.; Lenoir, F.; Parker, D. T.; Peng, Y.; Piizzi, G.; Wattanasin, S.</span><span> </span><span class="NLM_article-title">Organic Compounds for Application in Bacterial Infection Treatment</span>. PCT International Application PCT/EP2009/061905,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+R.+Dobler&author=F.+Lenoir&author=D.+T.+Parker&author=Y.+Peng&author=G.+Piizzi&author=S.+Wattanasin&title=Organic+Compounds+for+Application+in+Bacterial+Infection+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDobler%26aufirst%3DM.%2BR.%26atitle%3DOrganic%2520Compounds%2520for%2520Application%2520in%2520Bacterial%2520Infection%2520Treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretland, A. J.</span><span> </span><span class="NLM_article-title">Determination of Time-Dependent Inactivation of CYP3A4 in Cryopreserved Human Hepatocyctes and Assessment of Human Drug-Drug Interactions</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=2085-2092&author=Y.+Chenauthor=L.+Liuauthor=M.+Monshouwerauthor=A.+J.+Fretland&title=Determination+of+Time-Dependent+Inactivation+of+CYP3A4+in+Cryopreserved+Human+Hepatocyctes+and+Assessment+of+Human+Drug-Drug+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMonshouwer%26aufirst%3DM.%26aulast%3DFretland%26aufirst%3DA.%2BJ.%26atitle%3DDetermination%2520of%2520Time-Dependent%2520Inactivation%2520of%2520CYP3A4%2520in%2520Cryopreserved%2520Human%2520Hepatocyctes%2520and%2520Assessment%2520of%2520Human%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D2085%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gaither, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borawski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slisz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iourgenko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawel, L.</span><span> </span><span class="NLM_article-title">A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11493</span><span class="NLM_x">–</span> <span class="NLM_lpage">11498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11493-11498&author=A.+Gaitherauthor=D.+Porterauthor=Y.+Yaoauthor=J.+Borawskiauthor=G.+Yangauthor=J.+Donovanauthor=D.+Sageauthor=J.+Sliszauthor=M.+Tranauthor=C.+Straubauthor=T.+Ramseyauthor=V.+Iourgenkoauthor=A.+Huangauthor=Y.+Chenauthor=R.+Schlegelauthor=M.+Labowauthor=S.+Fawellauthor=W.+R.+Sellersauthor=L.+Zawel&title=A+Smac+Mimetic+Rescue+Screen+Reveals+Roles+for+Inhibitor+of+Apoptosis+Proteins+in+Tumor+Necrosis+Factor-%CE%B1+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaither%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DBorawski%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DSage%26aufirst%3DD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DIourgenko%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DLabow%26aufirst%3DM.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DZawel%26aufirst%3DL.%26atitle%3DA%2520Smac%2520Mimetic%2520Rescue%2520Screen%2520Reveals%2520Roles%2520for%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520in%2520Tumor%2520Necrosis%2520Factor-%25CE%25B1%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D11493%26epage%3D11498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400732v&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400732v&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400732v&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.-H.+Zhangauthor=T.+D.+Y.+Chungauthor=K.+R.+Oldenburg&title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eb75pVWZx6sQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520Simple%2520Statistical%2520Parameter%2520for%2520Use%2520in%2520Evaluation%2520and%2520Validation%2520of%2520High%2520Throughput%2520Screening%2520Assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU','PDB','4KJU'); return false;">PDB: 4KJU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a href="/doi/suppl/10.1021/jm400732v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70238"></div></div></div></div></div><hr /></hr><p class="last">Full procedures for compounds <b>7</b> through <b>26a</b>–<b>f</b>, crystallographic method, data collection, and refinement statistics. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400732v/suppl_file/jm400732v_si_001.pdf">jm400732v_si_001.pdf (879.96 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for <b>21j</b> bound to XIAP BIR2 shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU">4KJU</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400732v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm400732v%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-20" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400732v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a204ee9b2367","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
